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Persistent Genital Arousal Disorder (PGAD) is a complex, poorly understood condition 
characterized by unremitting, unwanted, distressing genital arousal which occurs 
frequently and for extended periods of time, often in the absence of sexual stimuli.  The 
pathophysiology is unknown.  Researchers have hypothesized underlying disorders of 
neurological, vascular, pharmacological and psychological origins.  Possible causalities 
have been suggested including anxiety disorder, SSRI use, and pudendal nerve 
neuropathies among others.  Despite the uncertainty of etiology, other aspects of the 
disorder are clearer, including distress and poor quality of life for many.  In this study, I 
used a biopsychosocial model to examine three potential psychological predictors— 
depression, stress, and anxiety—as well as moderators including erotophobia and 
perceived partner support on a sample of 51 women with PGAD.  Quantitative survey 
methodology was used to collect information from women with PGAD who had sought 
care for their condition from a sexual medicine specialty clinic (San Diego Sexual 
Medicine) and members of an online PGAD support group.  Results of the study 
indicated depression as the most significant predictor of distress of the three 
psychological variables under study.  Neither erotophobia nor perceived social support 
moderated any of the psychological factors studied.  Scores on the Female Sexual 
Distress Scale—Revised demonstrated clinically important levels of distress.  The 
findings highlight the need for a biopsychosocial treatment approach to the condition, 
including psychological therapy.  Implications for social change include the preservation 
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Chapter 1: Introduction to the Study  
Background  
 At the turn of the last century, a small group of women throughout the country 
were presenting to clinicians with symptoms previously undocumented in literature 
(Leiblum & Nathan, 2001).  These symptoms entailed feelings of persistent arousal in the 
genital area not accompanied by sexual desire or thoughts, and were deemed bothersome 
or distressful by the sufferers (Leiblum, Brown, Wan, & Rawlinson; 2005).  The women 
also indicated that the symptoms were often not relieved by one or more orgasms.  Pain, 
including pelvic, genital, and clitoral has been noted in some PGAD patients (Pink, 
Rancourt & Gordon, 2014).  Leiblum and Nathan (2001) originally deemed the cluster of 
symptoms persistent sexual arousal syndrome, but after further research, renamed the 
cluster of symptoms as persistent genital arousal disorder (PGAD) because the arousal 
was contained in the genital area and was unrelated to sexual desire or thoughts.   
Interestingly, significant variability in the distress women felt from PGAD symptoms was 
noted.  Some women reported little or no distress at all, while others indicated severe 
distress to the point of being unable to function well socially or in everyday life tasks and 
situations (Leiblum & Nathan, 2001).  Reports have indicated that symptoms may be 
triggered and/or exacerbated by levels of anxiety, stress and/or depression (Leiblum & 
Chivers, 2007; Leiblum, Seehuus, Golmeier & Brown, 2007; Leiblum et al., 2005). The 
literature shows that women with moderate to severe distress are appearing in clinicians 
offices seeking treatment, making it important for researchers to focus on distress 
variability, including its correlates or predictors, its causes, and its consequences.  
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Carvalho, Verissimo and Nobre (2015) recently completed a study examining 
contributors to distress including personality factors such as low openness to new 
experiences and ideas, neuroticism, and sexual beliefs. They noted that neuroticism, poor 
dyadic adjustment, sexually conservative beliefs, and low openness were significant 
predictors of distress; neither moderated the severity of PGAD symptoms and distress.  
Of these, sexually conservative beliefs were the most significant predictors of distress.    
Researchers have struggled to identify underlying causes of PGAD, and to date 
have yet to pinpoint a specific etiology.  They have speculated myriad potential etiologies 
including neurological, pharmacological, psychological, and vascular pathologies 
(Bedell, Goldstein, & Burrows, 2014; Waldinger, Venema, van Gils, & Schweitzer, 2009; 
Leiblum & Goldmeier, 2008; Goldmeier & Leiblum, 2008).  While prevalence is 
currently unknown, it is speculated that it may not be as rare as initially thought.  More 
women may experience similar symptoms and distress, but abstain from reporting to their 
clinicians out of embarrassment, shame, guilt, or cultural taboo (Leiblum, 2008; 
Mahoney & Zarate, 2007).  The prevalence may also be low because women presenting 
with symptoms may be inadvertently diagnosed with other conditions instead of PGAD. 
Problem Statement  
PGAD, a condition characterized by unwanted, bothersome genital arousal 
causing distress in the absence of sexual desire or stimuli and often not relieved by 
orgasm, was first identified as a clinical syndrome by Leiblum and Nathan (2001).  Five 
criteria make up the components of PGAD including: 
1. Persistent feelings of arousal extending over days, weeks, or months at a time. 
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2. The arousal is not alleviated by or only temporarily relieved by orgasm, 
sometimes requiring multiple orgasms. 
3. The arousal is not associated with sexual thoughts or desire. 
4. The arousal may be triggered by nonsexual stimuli or no apparent stimuli. 
5. The arousal is bothersome and causes distress. 
 Currently, only one case report of isolated PGAD has been presented in the 
literature regarding a male who presented with “persistent feelings of impending orgasm” 
similar to arousal and without priapism or sexual desire; and two cases of restless genital 
syndrome have been reported in males, but not as isolated PGAD (Stevenson & Kohler, 
2015; Waldinger, Venema, van Gils, de Lint, & Schweitzer, 2011).  
Distress, as noted above, is a key component of the five diagnostic criteria of 
PGAD.  It is not completely clear why some women experience high degrees of distress 
while others experience little or none at all.  In the limited research available, researchers 
have hypothesized that negative appraisal, high cognitive awareness, and sensitivity to 
one’s physical sensations causing greater anxiety are related to the differences in distress 
(Leiblum & Chivers, 2007; Leiblum, Seehuus, Goldmeier, & Brown, 2007).  Researchers 
have also suggested that feelings of shame, guilt, embarrassment and worry contribute to 
higher levels of distress (Leiblum et al., 2005).  The aforementioned study conducted 
most recently by Carvalho, Verissimo and Nobre (2015) targeted neuroticism, poor 
dyadic adjustment, low openness, and sexually conservative beliefs as potential distress 
triggers for some women.  Because most of the research on female sexual arousal and 
dysfunction has focused on deficiencies in arousal, the phenomenon of persistent, 
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distressful arousal continues to be a mystery.  Considering the hypotheses and findings in 
the work by Leiblum and Chivers (2007), Leiblum, Seehuus, Goldmeier and Brown 
(2007), and Carvalho, Verissimo and Nobre (2015), it is reasonable to theorize and to 
promote further research regarding a connection between PGAD distress levels and 
psychological factors such as anxiety, depression and stress, and sexually conservative 
belief systems whereby negative/conservative (erotophobic) beliefs and positive/liberal 
(erotophilic) beliefs may play a role. 
Distress, with regards to sexual dysfunction, has been a matter of discussion for 
many of the top researchers in the field (Hendrickx, Gijs, & Enzlin, 2013).  There are a 
host of arguments for keeping distress as a criterion for sexual dysfunction disorders, and 
just as many for taking it out.  Some researchers argue that distress is a consequence of a 
sexual dysfunction and is based on clinician or expert opinion as opposed to empirical 
data, and that measuring it tends to complicate research.  Others argue that, per empirical 
research, distress is not a factor or consequence for all women or men who experience 
sexual difficulty or dysfunction, and that it should be used to identity and work with 
individuals who desire treatment and seek out treatment options (Hendrickx, Gijs, & 
Enzlin, 2013).  With so much variability in levels of distress, some researchers have 
taken to assessing stress separately from sexual difficulties, arguing that a person can 
have a sexual dysfunction without having associated distress (Hendrickx, Gijs, & Enzlin, 
2013).  Leiblum and Chivers (2007) identified this concept in their study of two 
populations: women with persistent genital arousal disorder who were distressed, and 
women with persistent genital arousal who were not distressed.  
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Researchers have proposed several theories to explain the etiology of PGAD, such 
as the use of certain centrally-acting drugs such as SSRIs/SNRIs (Leiblum & Goldmeier, 
2008), dysfunction of the peripheral neuroanatomy (Bedell et al., 2014; Waldinger et al., 
2009), vascular concerns (Graziottin, 2004; Thorne & Stuckey, 2007), and psychological 
factors such as a subtype of anxiety disorder (Goldmier & Leiblum, 2008).  To date, all 
of these theories have limited empirical support, precluding definitive statements 
regarding the etiology of the condition.  Further, research to date has been hampered by 
the relative rarity and social stigmatization of the condition, as well as by a lack of 
theoretical framework guiding the research.  Carvalho, Verissimo and Nobre (2013) have 
recently explored psychogenic contributors, including dysfunctional cognitive and 
emotional factors during PGAD and non-PGAD women’s sexual activity, as potential 
contributors to the disorder.  Their research needs to be further expanded to consider the 
implications of dysfunctional cognitive and emotional factors not only during sexual 
activity, but also in everyday life.  
Purpose of the Study  
The purpose of this study was to fill a significant gap in the literature by 
providing a better understanding of significant predictors of distress in women with 
PGAD and moderators of said distress such as erotophobia-erotophilia and the nature of 
partner support. Leiblum and Chivers (2007) theorized heightened awareness of one’s 
physiological senses such as acknowledgment of genital arousal may spark a negative 
psychological response, increase anxiety levels, cue the sympathetic nervous system to 
increase activity, and ultimately increase focus on the genital arousal.  The two 
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researchers noted that anxiety disorders are reported at a higher frequency among those 
with PGAD who have higher distress rates than those who are not distressed.   
As defined by Fisher, Byrne, White and Kelley (1988), erotophobia-erotophilia 
“involves the disposition to respond to sexual cues with predictable degrees of negative-
to-positive affect and evaluations” (pp. 146-147).  When examined on a continuum, those 
on the negative (erotophobic) end tend to exhibit more avoidance responses to sexual 
cues and behaviors, while those on the positive (erotophilic) end tend to exhibit more 
acceptance or approach responses.  I sought to determine if anxiety would be the 
strongest predictor of distress, and if erotophobia-erotophilia and/or negative or poor 
emotional, instrumental (assistance with tasks), or informational (advice) partner support 
would moderate underlying anxiety, depression, and/or stress associated with distress in 
women with PGAD.  Such findings may assist clinicians with psychological treatment 
approaches to reducing distress in women with PGAD. 
Theoretical Framework  
The theoretical framework for this study was the biopsychosocial model.  George 
Engel (1980) made a strong case for use of this model in the fields of medicine, 
psychiatry, and psychology. He described the benefits of approaching the patient as a 
whole, utilizing a systems methodology of mind, body, and social influences. Engel 
articulated that the bottom-line goal for the patient is to relieve and alleviate distress, and 
proposed that in order to achieve this goal the healthcare provider must consider all 
angles of the problem being presented, whether medical, psychiatric, or psychological.  
With the biopsychosocial model, biological, psychological, and social influences should 
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all be considered when formulating hypotheses to etiology of illness or conditions 
presented. 
 In the area of sexual dysfunction, this model is decidedly relevant given that 
psychosocial factors often play a large role alongside possible biological concerns.  
McCabe et al. (2010) specifically addressed the need to include a biopsychosocial 
perspective when examining sexual dysfunction, particularly given how anxiety, 
depression, sexual and nonsexual partner concerns, and life stresses can vastly impact 
sexual function.  With respect to distress in PGAD, the biopsychosocial model can be 
used to examine the role of biological factors such as medical conditions and the 
aforementioned psychological predictors on levels of distress, as well as to examine if 
these predictors are moderated by social factors such as partner support or psychosocial 
factors such as erotophobia-erotophilia.   
Research Questions and Hypotheses  
Research Question 1.  Will anxiety be the strongest predictor of distress among 
the following three predictors: anxiety, stress, or depression? 
H01: Anxiety will not account for the most variance of the three predictors of 
distress in women with PGAD. 
H11: Anxiety will account for the most variance of the three predictors of distress 
in women with PGAD. 
Research Question 2.  Does erotophobia-erotophilia moderate the relationship 
between the strongest predictor (anxiety, stress, or depression) and level of distress? 
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H02: Level of erotophobia-erotophilia will not moderate the relationship between 
the most significant predictor and level of distress in women with PGAD. 
H12:  Level of erotophobia-erotophilia will moderate the relationship between the 
most significant predictor and level of distress in women with PGAD. 
Research Questions 3.  Does the nature of perceived partner support moderate the 
relationship between the strongest predictor (anxiety, stress, or depression) and level of 
distress for PGAD women with partners? 
H03: Nature of perceived partner support will not moderate the relationship 
between the most significant predictor and level of distress in women with PGAD. 
H13:  Nature of perceived partner support will moderate the relationship between 
the most significant predictor and level of distress in women with PGAD. 
Research Questions 4.  Is there a difference in distress levels for PGAD women 
with partners compared to PGAD women without partners? 
H04: Level of distress will not be different for PGAD women without partners 
than for PGAD women with partners. 
H14: Level of distress will be different for PGAD women without partners than 
for PGAD women with partners. 
Nature of Study  
This was a quantitative study.  Quantitative research is characterized by 
examining associations between variables to test theories (Creswell, 2014), which was 
the primary focus of this study.  The quantitative approach allows researchers to analyze 
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numerical variables captured via instruments such as survey questionnaires, and enables 
them to use appropriate statistical procedures and reporting.  
The independent variables in this study were anxiety, depression, and stress.  The 
dependent variable was the level of distress in women with PGAD.  Moderating variables 
were the level of erotophobia-erotophilia and the nature of perceived partner support.  
From a review of the literature, I identified the variables for this study which I 
then collected and measured via the survey method of collection and analysis.  I used the 
Female Sexual Distress Scale-Revised (FSDS-R), a validated 13-item questionnaire, to 
assess sexually-related distress in the absence of an available, validated PGAD-related 
distress scale (see Fisher, Davis, Yarber, & Davis, 2013).   
The instrument I used to assess depression, anxiety, and stress was the validated 
21-item Depression Anxiety Stress Scales (DASS-21).  There are seven items for each of 
the three factors. This instrument, using Cronbach’s alpha, has reliabilities of .88 for the 
Depression scale items, .82 for the Anxiety scale items, and .90 for the Stress scale items 
(Henry & Crawford, 2005). 
I used the Sexual Opinion Survey, a validated scale with adequate test-retest 
reliability (Davis, Yarber, Bauserman, Schreer, & Davis, 1998; Fisher, et al., 1988), to 
assess erotophobia-erotophilia. The Actually Received Support, a subscale of the Berlin 
Social Support Scales with a Cronbach alpha’s of .83, was utilized to examine the nature 
of perceived partner support (Schulz & Schwarzer, 2003). 
Demographic variables captured included age, race, education level, relationship 
status, sexual orientation, employment status, income level, and religion/spirituality.  
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Basic gynecological and medical history including pre- or post-menopausal, number of 
pregnancies, number of children, method of childbirth (cesarean or vaginal), history of 
overactive bladder, history of restless leg syndrome, history of Tarlov cysts, history of 
pudendal neuropathy, and history of sexually transmitted infections (STIs) were also 
collected.  I also collected data regarding onset of PGAD symptoms, exploratory distress 
and embarrassment levels, and whether a clinician was visited regarding PGAD and how 
satisfied the participant has been with clinician support.  Other than a minimum age 
requirement of 18 years and meeting the criteria for PGAD, no further inclusion or 
exclusion criteria were dependent upon demographic variables. 
Operational Definitions  
The following operational definitions are provided for clarification: 
Anxiety: Excessive worry or fear that may be combined with physiological and 
somatic symptoms such as irritability, inability to or difficulty in concentrating, fatigue, 
restlessness, tension, sweating, stomach upset, shakiness, and dry mouth (Wilson, 
Mannix, Oko-osi, & Revicki, 2015).  
Depression: A mood disorder encompassing such symptoms as sadness, lessened 
interest or pleasure, fatigue, appetite and/or weight changes, difficulty sleeping or falling 
asleep, difficulty concentrating, feelings of worthlessness, hopelessness, guilt, and 
sometimes suicidal thoughts or attempts (Fried & Nesse, 2015).  
 Erotophilia: A personality trait reflecting a positive attitude or disposition 
regarding sexuality (Macapagal & Janssen, 2011). 
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 Erotophobia: A personality trait reflecting a negative attitude or disposition 
regarding sexuality (Macapagal & Janssen, 2011). 
 Perceived partner support: The perception that an individual is cared for and 
assisted by their partner, and the partner is available to provide emotional, instrumental, 
and informational sustenance when needed (Girme, Overall & Simpson, 2015; Overall, 
Fletcher & Simpson, 2010). 
Stress: “An appraisal that one’s coping resources are inadequate in relation to the 
level of demands, prompting emotional, physiological, and behavioral changes that 
ultimately endanger well-being” (Amirkhan, Urizar Jr., & Clark, 2015, p. 985). 
Assumptions, Limitations, and Delimitations  
In this study, I assumed that (a) the self-report measures would yield valid data, 
(b) level of distress is a key component of PGAD, and (c) the instruments used for data 
collection would provide accurate measure of the variables under study.  Limitations of 
the study included a small sample size from a convenience sample of one medical facility 
specializing in sexual medicine and one online PGAD support group, reducing the ability 
for generalization to an overall population.  Delimitation of the study, resultant from time 
and financial constraints, included purposely choosing to use only the convenience 
sample as opposed to searching nationwide for other women with PGAD. 
Significance  
This project is important because there are currently limited data in the literature 
showing women with documented PGAD as having a potential association between level 
of distress and anxiety, depression, or stress. Further there is no literature in which 
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researchers have addressed the potential moderation of distress by the level of 
erotophobia-erotophilia and/or the nature of perceived partner support.  In a recent study, 
Carvalho et al. (2013) examined emotional determinants such as anxiety and depression 
in women with PGAD; however, their study limited this examination to beliefs, thoughts, 
and emotions during sexual intercourse.  Data from my research can be used to better 
understand the relationship between these phenomena without restricting the study to 
emotional determinants during sexual intercourse, and may indicate novel therapeutic 
modalities such as mindfulness or cognitive centered approaches based on expanded 
characterization of the disorder.  Given my use of the FSDS-R to measure distress, this 
study also provides a better understanding of sexual distress among women with PGAD, 
a phenomenon that has not been assessed in prior PGAD studies. 
PGAD is unfortunately associated with embarrassment and shame for many of the 
women suffering from the disorder (Leiblum, 2008). This can theoretically lead to 
women being less likely to report their symptoms to healthcare providers (Leiblum, 
2009), and increased distress and/or the development of suicidal ideation (Eibye & 
Jensen, 2014).  With so little research of the disorder in existence, women suffering from 
PGAD need more facts and clarity from well-conducted research in order to inform both 
the general public and clinicians about the nature of this disorder, the distress it brings, 
and viable treatment options.  By better characterizing the condition and exploring 
potential contributors to distress, we may be able to identify risk factors and triggers, a 




In this chapter, I have outlined the definition of PGAD along with the background 
of its recent introduction into the literature of sexual dysfunction.  I have provided 
theories regarding the low prevalence of information available to date, highlighting the 
need to fill the extraordinary gap in the literature.  Furthermore, the chapter has included 
an explanation of the purpose of the study, the theoretical framework upon which the 
study was built, and a summary the quantitative methodology used. 
Chapter 2 begins with an extensive overview of PGAD including the history, 
etiological theories, associated distress, and treatments attempted to date. Secondly, the 
chapter includes an explanation of how depression, anxiety, and stress have played a role 
in various areas of sexual dysfunction.  Finally, I discuss erotophobia-erotophilia and 
why this phenomenon may be a contributor to distress levels in women with PGAD, and 
provide an examination of the role of perceived partner support in illness. 
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Chapter 2: Literature Review 
Search Strategy 
Given the limited amount of research in the area of PGAD, I reviewed literature 
published from 1995 up until present time.  Databases I used to search for relevant 
literature included: Walden University’s Thoreau, PsycINFO and PsycTESTS, SCOPUS, 
OVID, MEDLINE, PubMed, ScienceDirect, and Google Scholar.  
 Key search terms and phrases I used as search criteria included persistent genital 
arousal disorder, persistent sexual arousal syndrome, PSAS, PGAD, restless genital 
syndrome, erotophobia, erotophilia, female sexual dysfunction, female sexual distress, 
social support, depression, stress, anxiety, distress, and sexual distress. 
Persistent Genital Arousal Disorder 
History 
PGAD first appeared in the literature in 2001 when Leiblum and Nathan (2001) 
published a seminal paper describing a rare condition they termed persistent sexual 
arousal syndrome.  In 2003 an international committee of sexuality experts assembled to 
recommend revisions in the classification of women’s sexual dysfunctions, and PSAS 
was provisionally included and characterized as: 
• Spontaneous, intrusive, and unwanted genital arousal (e.g., tingling, throbbing, 
pulsating), which occurs in the absence of sexual interest and desire.  
• Any awareness of subjective arousal is typically but not invariably unpleasant.  
• The arousal is unrelieved by one or more orgasms and the feelings of arousal 
persists for hours or days (Basson et. al, 2003).  
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Over the next few years, Leiblum and a small group of collaborators attempted to 
further explore this phenomenon using (novel at the time) internet methods to reach a 
larger sample of this rare phenomenon, culminating in recruitment of a sizable sample of 
women with PSAS (Leiblum, et al. 2005). The researchers used an in-depth, detailed 
questionnaire to obtain information from the subjects (N = 103), 56% of whom were 
subsequently characterized as having met criteria for PSAS.  In a subsequent study, 
Leiblum et al. (2007) recruited several other cohorts of women using online 
methodologies for data collection, and determined the nomenclature should be changed to 
the current persistent genital arousal disorder (PGAD).  Leiblum et al. surmised this to 
be a better reflection of the finding that this is a condition of genital rather than sexual 
arousal because sexual arousal and/or sexual desire and thoughts are often, if not always, 
absent, and that sexual behaviors such as masturbation or sex with a partner were used to 
relieve the genital arousal sensations.  Subsequently, five criteria were established as the 
diagnostic characteristics of PGAD, including:  
1. Spontaneous, persistent genital arousal such as clitoral tingling, throbbing, 
congestion, pain, pressure or spontaneous orgasm that occurs for an extended 
period of time, often hours, days, weeks or months. 
2. The arousal does not resolve or only temporarily resolves upon orgasm(s). 
3. The arousal is unrelated to sexual desire. 
4. The arousal may be triggered by non-sexual stimuli (e.g. riding in a car, riding 
a bicycle), sexual stimuli, or no stimuli at all. 
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5. The arousal is intrusive, unwanted, bothersome, and causes distress 
(Komisaruk & Lee, 2012; Leiblum et. al 2007). 
 Seeking to further understand the phenomenon, Leiblum and Seehuus (2009) next 
assessed overall sexual function using the validated Female Sexual Function index 
(Rosen et. al, 2000) to compare a cohort of women with PGAD to a cohort of women 
with female sexual arousal (FSA) disorder and normal controls, and found there was no 
evidence of any “hypersexuality” or excessive sexual desire (Carvalho et al., 2015) in the 
PGAD cohort. In fact, the researchers found that these women did not meet cutoff scores 
for sexual dysfunction at all.  Leiblum and Seehuus indicated that this might be due, in 
part, to women with PGAD associating their arousal symptoms with desire.  During this 
time, work by Chivers et al. (2004) into the nature of sexual arousal in non-PGAD 
women led to an understanding that genital arousal in women was a poorly and probably 
misunderstood phenomenon. Subsequently, Leiblum et al. (2007) further surveyed 388 
women online, some of whom indicated all five PGAD symptoms and some of whom did 
not.  The women with full-symptom PGAD reported greater levels of distress and 
symptom severity than those with non-full symptom PGAD, bringing the researchers to 
the conclusion that “there is a cohort of women who regularly, and intermittently, 
experience noticeable sensations of genital arousal that are pleasurable and even 
reassuring” (p. 686). There are other women, too, who experience more persistent 
feelings of genital arousal that is experienced as mildly distracting but not especially 
unwelcome or bothersome, as noted in a study conducted by Garvey, West, Latch, 
Leiblum and Goldmeier (2009), where, out of 96 women who completed the study, two 
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women reported having four of the five criteria for PGAD; however, they were not overly 
distressed by their symptoms, while three other women reported three of the five criteria 
for PGAD and experienced no distress or intrusiveness.  In one study, researchers noted 
that women with PGAD exhibited more negative thoughts during sexual intercourse such 
as those of sexual abuse or failure, more negative emotions during intercourse such as 
hostility or depression, and more conservative sexual beliefs such as sexual desire and 
pleasure being sinful, than did women without PGAD (Carvalho et al., 2013).  Although 
the aforementioned factors have been associated with PGAD, it is uncertain as to whether 
they are causal or a result of PGAD. Finally, there are also women who describe more 
continuous, intense, and persistent genital arousal that is reported to be extremely 
distracting, distressing, and worrisome. It is this last group of symptoms that has been 
labeled as PGAD (Leiblum & Chivers, 2007). 
Eventually, other researchers began to study this phenomenon, most notably 
Marcel Waldinger, a Dutch neuropsychiatrist. Waldinger et al. (2009) reported on a small 
(N = 18) cohort of women with PGAD who also presented with symptoms of overactive 
bladder (OAB) and restless leg syndrome ([RLS]; Waldinger et. al, 2009; Waldinger & 
Schweitzer, 2009). Based on this cohort of combined conditions, the researchers 
proposed a neurologic mechanism for the disorder, which they termed restless genital 
syndrome (Waldinger et. al, 2009).  The researchers used electroencephalograms (EEG) 
and magnetic resonance imaging (MRI) of the brain and pelvis to gain insight into 
potential biological pathologies for PGAD.  For any women who had abnormalities on 
these tests, transvaginal ultrasonongraphy and repeat MRI with contrast added were 
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performed to investigate potential causes of PGAD. They found that some women had 
pelvic and ovarian varices (dilated veins); however, the researchers concluded that no 
explicit pathology could be determined for the PGAD symptoms experienced by the 18 
women who participated, thus suggesting there may be no specific biological etiology.   
In more recent literature, researchers have continued to review the preceding body 
of evidence, as well as to report new cases and putative therapies (Rosenbaum, 2010; 
Ramic, 2013); however, there has been a paucity of original, systematic, prospectively 
designed research into the phenomenon.  Recent contributions have been made by 
researchers such as Carvalho et al. (2013) who have examined the correlates of PGAD 
with cognitive and affective aspects as well as with potential psychological moderators 
such as narcissism and neuroticism.  They found that, although not necessarily causal or a 
result of PGAD, women with PGAD symptoms had higher levels of sexual conservatism 
and more negative affective states (e.g. low excitement, low interest, distressed) and 
thoughts (e.g., lack of affection from partner) during sexual activity than women without 
PGAD.  Yildirim, Hacioglu, Essizoglu and Kucukparlak (2012) raised the concern of 
underreporting or misdiagnosis of PGAD in three case studies of Muslim women 
previously diagnosed with obsessive-compulsive disorders.  The diagnosis was based on 
the grounds of bathing rituals practiced by these women upon sexuality-related behaviors 
such as intercourse, orgasm, and even menstruation.  Because these women were bathing 
multiple times per day due to their persistent arousal and orgasms, and were hesitant to 
discuss their concerns due to fear of being seen as hypersexual, they were instead treated 
for OCD and subsequently received no relief.  Fear, guilt, shame, and embarrassment 
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have been cited across the literature as the potential reasons behind low reporting levels 
of PGAD (Markos & Dinsmore, 2013; Leiblum, 2008; Mahoney & Zarate, 2007). 
Etiology 
The etiology of PGAD remains a mystery.  Graziottin (2004) identified the 
potential for neural problems as an underlying cause of genital arousal disorders.  Others, 
such as Leiblum (2009), have concurred with this theory, suggesting that pelvic nerve 
hypersensitivity or brain lesion anomaly may play a role.  
As clinicians began to grow more aware of the phenomenon, case reports as well 
as putative therapies began to appear in the literature (Goldmeier & Leiblum, 2008).  
Cases associated with medication-induced changes such as antidepressant use and 
withdrawal (Leiblum & Goldmier, 2008), vascular malformations (Bedell et al., 2014), 
psychological factors (Leiblum et al., 2005), and the presence of Tarlov cysts (defined as 
sacral region cysts; Komisarik & Lee, 2014; Eibye & Jensen, 2014) have been reported, 
challenging the search for an underlying or unifying theory of etiology. As an example of 
the variety of etiological possibilities, Pink, Rancourt, and Gordon (2014) reported on a 
group of 15 women who presented at a pain clinic for pelvic and/or genital pain, bladder-
related pain, headache, and other non-cancerous pain conditions with concomitant 
symptoms of PGAD.  One of the participants was noted to have a Tarlov cyst, one had 
adenomyosis (endometrial tissue growing in muscle outside the uterus), and one had non-
specific foci (white spots) of the brain noted on MRI.  Physical examination of the 
women showed nine positive Q-tip tests (a cotton swab placed in the urethra to evaluate 
urethral mobility), four with pain on palpation or digital exam, three with clitoral pain, 
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one with clitoral swelling, one with hyperalgesia (increased sensitivity to pain), and one 
with hypoesthesia (reduced sensation to stimuli, particularly touch).  A third of the 
women had been taking SNRIs either currently and/or in the past, while a quarter of the 
women were on SSRIs in the past.  Approximately 50% of the women in this cohort had 
taken tricyclic antidepressants in the past.  Five of the women reported having restless leg 
syndrome, nine had a history of depression, and six suffered from anxiety.  Vincenzo 
Puppo (2014) argued, in a letter to the editor of The Journal of Obstetrics and 
Gynaecology Canada, against the Pink et al. report, suggesting that PGAD should not be 
the nomenclature used for this cluster of symptoms, but rather female priapism.  He 
indicated that the symptoms are more in line with that of female priapism, a condition 
consisting of prolonged erection of the clitoris unassociated with sexual arousal and 
causing pain and swelling in the surrounding areas as well.  Pink et al. (2014) offered an 
extensive rebuttal to his letter, sufficiently explaining why his argument does not hold for 
several reasons, including that the most substantiating symptom of PGAD is arousal, 
whereas priapism is unrelated to arousal.  Pink et al. also pointed out that Puppo failed to 
associate the chronicity of PGAD to priapism, whereby PGAD often occurs for months, 
while priapism generally occurs for hours. 
Pelvic Congestion and Varices. In an earlier paper, Graziottin (2004) ascertained 
that PGAD could be described as a painful congestion of the genitalia accompanied by 
persistent arousal not relieved by orgasm, resulting in distress and removing all feelings 
of pleasure.  Thorne and Stuckey (2007) presented a case report of a 62-year-old woman 
diagnosed with pelvic congestion syndrome, a chronic condition caused by varicose veins 
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in the pelvic region.  She also presented with ovarian vein incompetencies and 
complained of PGAD.  Several varices (dilation of veins) were noted in her pelvic and 
genital regions upon ultrasound and MRI examinations. Upon endovascular coil 
embolization (blockage of blood flow) of the ovarian vein, the patient experienced 
approximately 70% relief of persistent arousal symptoms. These researchers concurred 
that pelvic congestion syndrome should be considered a high possibility among etiologies 
being suggested. 
Krapf and Goldstein (2013) recently reported on two cases whereby PGAD was 
concomitantly present in a 25-year-old woman and a 22-year-old woman who both 
appeared to suffer from a condition known as hypermobility-type Ehlers-Danios 
syndrome, a connective tissue disorder causing chronic musculoskeletal and joint pain. 
The authors identified the condition as “a collagen disorder that may have gynecologic 
manifestations” (p. 2347).  In each of these women, stark labial edema (swelling of the 
labia) was present along with bladder pressure upon intercourse in the 25-year-old 
woman, and pain and sensitivity upon intercourse in the 22-year-old woman.  A third 
case of PGAD being concomitant with Ehlers-Danlos syndrome was noted by Pink, 
Rancourt, and Gordon (2014) in their aforementioned cohort study above. Because these 
are the only three cases of this reported in the literature, etiological generalization would 
be inappropriate at this time.   
In 2008, Marcel Waldinger et al. conducted an extensive study of 18 Dutch 
women diagnosed with PGAD.  The researchers used brain and pelvic MRI, 
electroencephalogram (EEG), transvaginal ultrasound (TVUS), and blood samplings to 
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look for any marked findings or similarities among the women.  Over half of the women 
were noted to have pelvic varices ranging from mild, moderate to severe, with the 
majority of those being mild to moderate.  Interestingly, several of the women also were 
noted to have had leg varices. 
Tarlov Cysts.  Tarlov cysts, otherwise known as perineural or sacral cysts, are 
fluid-filled cysts that form on the dorsal roots of the sacral region (S1 – S4) of the spinal 
canal, typically around S2 and S3 (Komisaruk & Lee, 2012).   As mentioned by 
Komisaruk and Lee (2012), the dorsal roots are associated with the sensory pudendal and 
pelvic nerves, which intertwine with both internal and external genitalia and have the 
potential to promote atypical genital sensations, bringing rise to the hypothesis that 
Tarlov Cysts could be implicated as an etiology for PGAD.  
   Komisaruk and Lee (2012) conducted a study involving the use of a PGAD 
support group to recruit women who had prior MRIs.  The researchers evaluated the 
MRIs of 18 women who self-reported PGAD (a limitation of the study) and noted that 12 
of the 18 women had notable Tarlov cysts.  Five of the 12 women had one cyst, six of the 
12 women had two cysts, and one of the 12 women had three cysts.  The researchers 
noted that in the general population, Tarlov cysts appear in 1.2 – 9% of the population 
and thereby concluded that Tarlov cysts could be considered a conceivable etiology for 
PGAD.  Eibye and Jensen (2014) confirmed a Tarlov cyst present in a case report of a 31-
year-old female presenting with PGAD among other comorbidities including depression, 
anxiety and somatization.  
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Restless Genital Syndrome.  In 2009, Marcel Waldinger and Dave Schweitzer 
conducted a second review on the 18 Dutch women mentioned above.  In their “Part 2” 
review of the data, they noted that 12 (67%) of the 18 women not only suffered from 
PGAD, but also experienced restless leg syndrome (RLS) and overactive bladder with a 
frequency in micturition (the urge for emptying their bladders), which led to subsequent 
brief relief of PGAD symptoms. RLS is defined as “a neurological disorder characterized 
by throbbing, pulling, creeping, or other unpleasant sensations in the legs and an 
uncontrollable, and sometimes overwhelming, urge to move them” (National Institute of 
Neurological Disorders and Stroke, 2010).  The researchers found that several of the 
women reported their RLS onset occurring at the same time as or prior to their PGAD 
onset.   Waldinger and Schweitzer (2009) noted the similarities between RLS and PGAD 
such as, but not limited to, the uncomfortable sensations, the urge to alleviate the 
sensations through movement or rubbing the inflicted area, and varices in the inflicted 
regions (pelvis and legs). They further reported a “clustering” of these symptoms and 
theorized they could be lumped into a condition they deemed restless genital syndrome 
(RGS), a more complex syndrome that encompasses RLS, PGAD, overactive bladder and 
urethra hypersensitivity. Markos and Dinsmore (2013) concurred with the notation of 
similarities between PGAD and RGS and went on to suggest that these similarities can 
also be found in vulvodynia, a condition involving chronic pain of the external genital 
region. In their 2013 manuscript, Markos and Dinsmore suggested that PGAD and RGS 
be considered subtypes of vulvodynia and argued that it should be reclassified as a pain 
disorder as opposed to a sexual dysfunction, which appears to be based upon their 
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interpretation of the similarity in symptoms and the evolving definition of vulvodynia 
over the past few decades. 
Waldinger continued his research with Schweiter as well as Venema and van Gils 
(2009), utilizing the data from 12 of the 18 PGAD patients above and adding another 11 
new PGAD women to conduct further testing and analysis of his newly defined RGS.  
The results of this study concluded that, in fact, all the women examined presented 
varices in the pelvic region and seven of them had varices in the legs.  Eighteen of the 23 
women reported RLS and sixteen reported overactive bladder.  These figures give further 
merit to the theory of a clustering of symptoms grouped together as restless genital 
syndrome.   
In this same study, the researchers also used a new approach in their examinations 
called genital tactile mapping testing (GTM) to conduct pressure point touch responses in 
the hopes of mapping the specific genital region involved in RGS.  Using a cotton swab 
on the skin, the researchers touched upon several pressure points with fixed pressure on 
or around the genitals, the pubic bone, the groins, the anal area and the perineum to test 
for tactile sensations. Various trigger points were noted among the women, including the 
area above the pubic bone in 11 of the women and ranging moderately across all of the 
other aforementioned areas resulting in hypersensitivity from light to moderate pressure, 
as well as repeated intense orgasm in three of the women.  For four of the women, the 
clitoris was the only notable trigger point to spark RGS. 
Pudendal Neuropathy.  It is speculated that the pudendal nerve, originating from 
the pudendal plexus in the S2-S4 sacral region, and the dorsal nerve of the clitoris (DNC) 
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play a role in RGS and PGAD.  The pudendal nerves extends from the pudendal plexus to 
the pudendal canal, perineum and gluteal regions, and has been previously identified as 
contributing to bladder issues, pelvic/genital/rectal pain and sexual dysfunction (Possover 
& Forman, 2012),  giving feasibility to the theory of its involvement in RGS and PGAD.  
The DNC function, however, is not quite clear, though in the Waldinger et. al (2009) 
study it was found to induce pre-orgasmic and orgasmic sensations albeit a lack of sexual 
desire. 
Medication-Induced Changes.   Researchers have presented case studies in the 
past noting patients who have developed PGAD upon use, change, or discontinuation of 
prescription medications such as selective serotonin reuptake inhibitors or serotonin and 
norepinephrine reuptake inhibitors.  In particular, Battaglia and Venturoli (2009) shared a 
case study of a 29-year-old woman presenting with PGAD as well as uncontrollable 
orgasms for two years upon the use of Trazadone for depression/anxiety. Increased 
sexual arousal and spontaneous orgasm began one month into Trazadone use.  The 
medication was abruptly stopped after three months; however, the persistent arousal and 
spontaneous orgasms remained, although slightly decreased. Clitoral and vaginal 
congestion were noted by the patient during examination by the researchers who 
suggested further study into clitoral vascularization in order to better understand what 
may be occurring in these cases.  Leiblum et al. (2007) also suggested that, in some rare 
instances, clitoral priapism (an occurrence involving “increased intracavernosal pressure 
or vascular outflow problems” (p. 1359)) may be camouflaged as PGAD.   
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In another case study, Mahoney and Zarate (2007) discussed a 32-year-old 
woman who reported increased clitoral sensation and PGAD-like symptoms upon an 
increase in venlafaxine dosage.  Elimination of symptoms occurred for this particular 
patient upon dose reduction.  In further research, using results from an online survey of 
364 women conducted in 2005, Leiblum and Goldmeier (2008) found six women who 
indicated that symptoms of PGAD began upon the usage or discontinuation of SSRIs.  
Goldmeier, Bell, and Richardson (2006) hypothesized that discontinuation of SSRIs may 
trigger PGAD in women via withdrawal syndrome phenomena. This includes the 
potential for high production levels of atrial natriuretic peptide (ANP), which is related to 
vasodilatation and increased vascular endothelial permeability, potentially resulting in 
vasocongestion and edema in the genital region.   
In the aforementioned Eibye and Jensen (2014) case, the woman had been 
previously diagnosed with dependent personality disorder and was prescribed a variety of 
different antidepressants and anti-anxiety medications.  Per the patient, her PGAD 
symptoms began upon cessation of paroxetine, an SSRI used in the treatment of her 
psychological distress.  Paroxetine was restarted in the hopes of alleviating the 
symptoms; however, complete relief was not obtained and, in fact, worsened upon the 
addition of agomelatine, another antidepressant. 
Psychological Correlates. In 2007, Leiblum et al. sought not only to explore the 
medical and pharmacological correlates of PGAD, but also the psychological correlates. 
They noted that women with PGAD were “more likely than women who only met some 
of the criteria to report depression, anxiety, panic attacks, and certain obsessive-
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compulsive symptoms such as monitoring their physical sensations.”  The authors 
hypothesized that for some women with PGAD, “psychological factors, namely anxiety, 
reinforce, exacerbate and maintain PGAD.”  Gadit (2013) presented a case report of a 54-
year-old woman suffering from comorbidities of PGAD, including anxiety, obsessive-
compulsive behavior, and non-specific stress syndrome, all of which were reported prior 
to the patient receiving prescribed medications.  Stress induced psychological changes 
have also been attributed to exacerbating PGAD (Leiblum, 2009).  Hamilton and Meston 
(2013) implicated chronic stress, including distraction in women with high chronic stress, 
as a contributing factor to sexual dysfunction. Leiblum and Goldmeier (2008) as well as 
Pink, Rancourt and Gordon (2014) have noted depression as a noteworthy correlate in 
women experiencing sexual dysfunction.  Leiblum and Goldmeier pointed out that in 
some studies in upwards of 70% of women who suffered from major depression reported 
difficulties with sexual function.  Pink, Rancourt and Gordon noted over half (60%) of 
their study cohort of 15 women had symptoms of depression.  Anxiety was also noted in 
six (40%) of their 15 participants. While these factors have been associated with PGAD, 
no cause or effect relationship has been determined. 
Other Associations. Other researchers have looked at further associations of PGAD 
factors.  A case report by Anzellotti et al. (2010) centered on PGAD being associated 
with an epileptic focus in a 40-year-old female.  This female had no notable 
abnormalities on prior MRI and EEG screenings.   Upon administration of an anti-




One of the five diagnostic criteria of PGAD is that the arousal is intrusive, 
unwanted, bothersome and causes distress.  Leiblum and Chivers (2007) noted varying 
levels of distress in women with PGAD and suggested three overall categories of arousal 
in women including: a) unprompted genital arousal sensations that are perceived as 
somewhat pleasurable; b) chronic arousal that is perceived as distracting but not 
distressful or unwelcome; c) chronic, intense arousal that is distressful, unwelcome and 
bothersome.  The researchers provided statements from two women from an online 
survey who had several symptoms of PGAD without the distress, and appear to both 
accept and welcome their symptoms.  One woman went so far as to state she hopes her 
symptoms remain into her senior years. These are followed by contrasting statements 
from others such as that of a 38-year-old woman indicating both the need to masturbate 
multiple times per day to relieve her unbearable genital sensations starting in early 
childhood years and the shame and guilt she felt in doing so. With so little research 
existing on PGAD overall, it is extremely difficult to find even minimal literature 
focusing solely on distress factors (none of which examine sexual distress) and the 
underlying influences for the variations in distress levels among PGAD women.  The 
limited research available theorizes that negative appraisal, variability in intensity and/or 
length of the genital sensations, high cognitive awareness, and hypersensitivity to one’s 
physical sensations resulting in anxiety could be implicated as distress predictors 
(Carvalho et al., 2015; Leiblum & Chivers, 2007; Leiblum et al., (2007).   Leiblum and 
Chivers (2007) also noted that psychological attributes may be the etiological culprits in 
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cases where physical attributes cannot be ascertained.  They proposed the following 
model: 
1) “Women detect a spontaneous genital sensation;  
2) They appraise their sensation or response as negative or inappropriate; 
3) They experience anxiety subsequent to their appraisal; 
4) The anxiety subsequently increases sympathetic nervous system 
activity, enhancing their perceptions of and attention to their genital 
sensations”; (p. 368). 
Social and cultural constraints regarding women’s sexuality including sex 
negativity may contribute to feelings of shame, guilt, embarrassment and worry 
contributing to higher levels of distress, including sexual distress (Leiblum & Chivers, 
2007; Leiblum et al., 2005). Most recently, Carvalho et al. (2015) examined personality, 
sexual beliefs and relationship adjustment as contributors to PGAD. They found that 
neuroticism, as a personality factor, did not have a significant impact on distress in 
PGAD, while low openness did, and that dyadic adjustment and sexually conservative 
beliefs were significant predictors of distress.  Again, these factors are only found to be 
associated with PGAD and not causal or consequential therefore limiting generalization.   
Treatment 
 Definitive treatments for PGAD are still uncertain.  Different treatment 
approaches have been utilized dependent upon the hypothesized pathology of the PGAD. 
In some instances, cognitive behavioral therapy or counseling has been utilized to assist 
with negative cognitions and stress (Leiblum & Goldmeier, 2008; Leiblum, Seehus, 
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Goldmeier, & Brown, 2007; Gadit, 2013).  In other cases, patients were treated by 
targeting Tarlov cysts with nerve or epidural blocks, or given anti-seizure medication, 
mood stabilizers (Komisaruk & Lee, 2012) or antidepressants, though this remains 
controversial as SNRIs and SSRIs have been noted as potential triggers of PGAD (Pink, 
Rancourt, & Gordon, 2014; Gadit, 2013).   
 Korda, Pfaus, Kellner and Goldstein (2009) presented a case report of a bipolar 
(type I) female with PGAD who was treated with electro-convulsive therapy (ECT), 
resulting in temporary relief of symptoms, slowly relapsing over time.  Gadit reported on 
a patient who was offered ECT but was uncomfortable proceeding with the treatment. 
Waldinger et al. (2010) discussed a case report of a 77-year-old woman who underwent a 
clitoridectomy with moderate relief from spontaneous orgasm but little relief from 
arousal symptoms and sensations.  In another study by Waldinger et al. (2009), two 
women who presented with RGS were given transcutaneous electrical nerve stimulation 
(TENS) with positive results. One of the women had a 90% reduction in spontaneous 
orgasm as well as immediate relief from other arousal symptoms, while the second 
woman obtained complete relief of genital symptoms over a two-month period.  
 Philippsohn and Kruger (2012) presented case studies of two women: a 36-year-
old treated with duloxetine and a 41-year-old treated with pregabalin, an SNRI and a 
gamma-Aminobutyric acid analog anticonvulsant and analgesic often used in neuropathy, 
respectively.  The duloxetine treated woman obtained full remission from her symptoms 
while the pregabalin treated woman received substantial but not full relief.  On the other 
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hand, Gadit (2013) reported a patient was taking Citalopram, Clonazepam and Zopiclone 
with little effect on PGAD symptoms. 
 In Waldinger’s and Schweitzer’s (2009) Dutch study, the authors noted the 
participants had obtained various treatments over time with little or no improvement, 
including pelvic floor exercises, pharmacological treatment including antidepressants 
and/or cyproterone acetate and psychotherapy.  Three women were prescribed 
pramiprexol, a non-ergoline dopamine agonist used in RLS and Parkinson’s, with no 
improvement.  Three women were given tramadol, an opioid used for pain, resulting in 
temporary (approximately 4 hours) reduction of symptoms for two of the women.  Three 
women were given oxazepam, a benzodiazepine used for anxiety and depression, with 
reports of symptom reduction in two and overall relief in one. Finally, two menopausal 
women were given hormone replacement therapy (HRT) with symptom improvement in 
one woman but not the other. 
 Rosenbaum (2010) provided a case report of a 27-year-old pregnant woman who 
received pelvic floor manual therapy focusing on the pudendal nerve.  Per the patient, the 
symptoms of PGAD significantly reduced after approximately one week of therapy.  
Upon 10 and 14 week follow up phone contacts, the patient indicated complete resolution 
of symptoms.  
 In one case, a 71-year-old woman, with comorbidity of Parkinson’s disease (onset 
ten years prior to PGAD onset) received nine sessions of hypnotherapy as treatment 
approach to her PGAD symptoms (Elkins, Ramsey, & Yu, 2014).  Her symptoms first 
appeared shortly after a Mirapex (pramiprexole) dose increase.  The patient had 
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previously used Lidocaine and ice baths for her symptoms, but with minimal temporary 
effect. Upon completion of the nine hypnotherapy sessions, the woman showed marked 
improvement in her PGAD symptoms. 
 As many of these treatment approaches consist of only single case reports or 
small participant numbers, it is difficult to surmise or generalize consistent, appropriate, 
effective treatment patterns across the population.  Further research on PGAD treatments 
is direly needed. 
Depression, Anxiety and Stress in Sexual Dysfunction 
Research over the last decades has shown consistent associations between sexual 
dysfunction and affective states, depression, and anxiety (Lewis et al, 2010, Laumann, 
Paik, & Rosen, 1999; Shifren, Monz, Russo, Segreti,& Johannes, 2008).  Unfortunately, 
almost all of these studies have significant methodological problems and have been 
largely cross-sectional.  Thus, despite the plethora of correlations noted, to date almost no 
longitudinal or experimental studies have been undertaken that would demonstrate 
potential causality between the occurrence of sexual dysfunction and these affective 
disorders.  Although this study will also have the limitation of being cross-sectional due 
to time and financial constraints, the study is expected to add a significant contribution to 
the limited PGAD research available. 
Lovibond and Lovibond (1995) examined the DASS (Depression Anxiety Stress 
Scales) scales to determine overlap potential among depression, anxiety and stress.  
While they noted that some overlap does occur, particularly between anxiety and stress, 
the scale does portray notable differences among the three constructs.  Depression was 
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marked by low or loss of self-esteem, loss of incentive, and a low perception of life goal 
achievability among the more commonly addressed symptoms of sadness and 
worthlessness.  Anxiety was marked by nervousness, shakiness, dry mouth, panic, fear 
and worry.  Stress was marked by difficulty with relaxing, nervousness (overlap with 
anxiety), agitation, irritability and impatience.   
Anxiety.  From Freud’s earliest writings, anxiety played a significant role in early 
psychodynamic formulations of sexual dysfunction and later became the foundation for 
the etiological concepts of sex therapy established by Masters and Johnson and Helen 
Singer Kaplan.  Indeed, Kaplan (1995) asserted that sexually-related anxiety was “the 
‘final’ common pathway via which various biological and psychosocial factors influence 
the modulation and adjustment” of human sexuality (p. 19).  More recently, studies have 
repeatedly found that individuals with sexual dysfunction exhibit heightened levels of 
anxiety, supporting the possibility of a central role of anxiety in the subjective experience 
and maintenance of sexual concerns.  
The central role of anxiety historically reported by sex therapists (Kaplan, 1995; 
Rosen & Leiblum, 1995) has been challenged by a number of sophisticated laboratory 
studies aimed at unraveling the sequence of cognitive-affective processes during sexual 
arousal in dysfunctional and functional men and, to a lesser extent, women. Contrary to 
the clinical studies’ findings for an inhibition effect of anxiety, the laboratory evidence 
indicated that anxiety (as induced in the lab setting) either facilitates or does not affect 
sexual arousal in sexually functional subjects. The evidence for sexually dysfunctional 
subjects is more mixed (Mitchell, DiBartolo, Brown, & Barlow, 1998). 
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Anxiety researcher David Barlow offered a theoretical model explaining why 
anxiety may operate differentially in subjects with and without sexual dysfunction.  His 
model emphasizes the role of cognitive interference; in general, he suggests that what 
distinguishes functional from dysfunctional responding is a difference in selective 
attention and distractibility (Barlow, 1986).  What has long been described clinically as 
performance anxiety, or fear of inadequacy or “spectatoring” can all be seen as a 
situation-specific cognitive activity that distracts dysfunctional individuals from 
processing of stimuli in a positive sexual context (Althof et al., 2005).  Experimental 
psychophysiology studies in women suggest the relationship between anxiety and sexual 
function is mixed, with the suggestion that it is more negative than enhancing (Meston & 
Bradford, 2007).  Leiblum and Chivers (2007) addressed both the hyperactive 
physiological and psychological effects anxiety can produce within the body, thus 
providing conceptual support for the hypothesis that anxiety will be the strongest 
predictor of PGAD in this study. 
In summary, psychophysiology studies examining the relationship between 
anxiety, distraction, general sympathetic activation, and sexual response have 
demonstrated that anxiety is not universally disruptive to sexual functioning in women 
(Wiegel, Scepkowski, & Barlow, 2006).  Importantly, results have suggested that the 
relationship between anxiety and sexuality – particularly in women - is complex, with 
evidence suggesting context, level and the nature of anxiety and its history are important 
determinants. As an example, moderate anxiety and perceived “safe” settings may 
heighten sexual arousal, while higher levels of anxiety, loss of personal control, or a 
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history of abuse seem to impair sexual functioning (Meston et al., 2006; Lemieus & 
Byers, 2008). 
Depression.  Although sexual arousal disorders have not been as extensively 
investigated in women as in men, it is generally accepted that there is a bi-directional 
impact of depressive symptomatology and sexual function. Clinical treatment guidelines 
recommend that women with depressive symptomatology be screened for sexual 
dysfunction and vice versa, that women presenting with sexual dysfunction be assessed 
for the presence of depression (Basson et al., 2004; Althof et al., 2005; McCabe et al., 
2010).   
In his landmark study of sexual concerns in the United States, Laumann et al. 
(1999) reported a latent class analysis demonstrating that depressive symptoms and/or 
stress predicted a 4.6 times greater likelihood of arousal disorder in women.  A study in 
the UK utilizing similar methodology by Dunn, Croft and Hackett (1999) found that in a 
community sample of 615 women, self-reported problems with arousal were six times 
more likely in women with, versus those without, depression. 
 Cyranowski et al. (2004a) noted that arousal was significantly lower in a sample 
of 914 women with recurrent major depressive disorder compared to women with no 
history of depressive disorder.  This was so even when controlling for current depression 
scores, psychotropic medication use, comorbid anxiety or substance abuse; whereas 
women who had only a single episode of major depression did not show such an effect. 
Another study by Cyranowski et al. (2004b) showed that of 68 women experiencing at 
least their 2nd episode of major depression and not using psychotropic medication at 
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study entry, 41% reported that in the past 30 days they had not had normal lubrication 
throughout sexual relations.  Even after interpersonal therapy, an assessment at 12-
months showed that 38% of women still reported disturbances in arousal, suggesting that 
sexual symptoms comorbid with depression do not easily disappear, even when the 
depression is treated and/or in remission. Similar findings were reported by Kennedy, 
Dickens, Eisfeld, and Bagsby (1999), in which similar rates of dysfunction with arousal 
was noted in a sample of 102 depressed women, 50% of whom reported less sexual 
arousal overall, and 40% reporting difficulty in achieving adequate vaginal lubrication.   
In women, only one experimental study was found involving depression and 
arousal.  In this repeated measures psychophysiology experiment, 56 women with normal 
sexual function were classified as either depressive or not and vaginal 
photoplethysmography was taken as an objective measure of sexual arousal; self-report 
measures of arousal were also taken.  Although there were no significant differences 
between women classified as depressed or not depressed on objective or subjective 
measures of arousal, the findings suggested that holding negative thoughts or affect that 
are experienced before sexual activity commences can decrease sexual responding, even 
when positive affect is introduced later (Kuffel & Heiman, 2006).  
 Stress. The potential role of stress in sexual dysfunction is far more difficult to 
assess, because stress can be conceptualized in many different ways.  In their study of 
older American sexuality, Laumann et al. (2008) noted “sexual problems among the 
elderly seem more of a response to stressors in multiple domains of life, from physical 
health to features of the intimate relationship” (p. 2309).  Similarly, broad findings were 
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noted by Shifren, Monz, Russo, Segreti, and Johannes (2008) in their large (N = 31,581) 
survey of women. They found that poor self-assessed health, low education level, 
depression, anxiety, thyroid conditions, and urinary incontinence all correlated with 
distressing sexuality.  Thus, while stress appears to be implicated negatively with sexual 
function, a specific role that can be parsed out does not present itself given the broad 
nature of the construct and the variability to what may constitute stressors to an 
individual. The literature does not reflect it having ever been tested in a prospective 
manner as to do so would require a complex longitudinal methodology, e.g. recruitment 
of a cohort with low stress, anxiety and depressive symptoms at baseline in order to 
ascertain the relationship between the variables over time. Alternatively, although more 
experimental in nature, a cohort of subjects could be recruited and their subjective and 
objective sexual responses assessed in response to sexual stimuli in the presence or 
absence of co-administered stress stimuli. 
Erotophobia and Erotophilia 
As indicated by Macapagal and Janssen (2011), sex involves a wide range of 
emotions, sentiments, reactions, and connotations, some positive and some negative. 
Sexuality experts have noted that all individuals can be categorized as having an 
erotophobic or erotophilic disposition (Furnham & Hirandani, 2009; Fisher, Byrne, & 
White, 1983).  Erotophobia falls at the negative end of the erotophobia-erotophilia 
spectrum eliciting negative responses to sexual stimuli, while erotophilia falls at the 
positive end, igniting positive responses to sexual stimuli (Furnham & Hirandani, 2009; 
Fisher et al., 1988). Byrne and Kelley (1986) contended that those individuals who fall 
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somewhere in the middle of the spectrum have a greater tendency to lean more toward 
erotophilia as they gain more gratifying sexual experiences over time. 
  Furnham and Hiranandani (2009) indicated that sex guilt mediates negative 
emotions such as anxiety and avoidance reactions in erotophobes in response to sexual 
stimuli.  Such sex guilt may consist of anxiety-inducing emotions when thoughts or 
feelings related to sexual behavior arise in the erotophobe (Furnham & Hirandani, 2009). 
Hall, Hogue and Guo (2014) contended that erotophobic individuals have higher sex guilt 
than erotophilic individuals.  Researchers also note that sex can elicit not only guilt, 
avoidance and anxiety, but also disgust, annoyance, threat (Cherner & Reissing, 2013) 
and distress for some individuals, including those who are considered erotophobic or 
even those suffering from sexual dysfunction (Macapagal & Janssen, 2011; Wiegel, 
Scepkowski, & Barlow, 2007).  In the aforementioned case report by Rosenbaum (2010), 
the 27-year-old pregnant woman suffering from PGAD  expressed feelings of concern 
regarding her newly compulsive need to masturbate to relieve her symptoms because of 
her religiosity, role identity and self-image.  Per the case report, the woman indicated she 
attributed arousal to sexual feelings, which should only be experienced through sexual 
relations with her spouse, and therefore was distressed by her “overly sexual” symptoms 
(p. 1307).  
An earlier study by Helweg-Larsen and Howell (2000) regarding the processing 
of sexually related material supported the theory of avoidance in that it showed women 
who were considered erotophobic, or sex negative, were more likely to avoid sexual 
information, and that erotophobia appears to interfere with centrally-routed processing of 
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sexual information.  Smith, Hedges, Gerrard, and Gibbons (1996) found similar results in 
their study in that sexually related cognition and concepts may be altered dependent upon 
one’s tendency to be considered either erotophobic or erotophilic. 
 Other researchers such as Evans (2000) have noted that myths relating to sex 
contribute to erotophobia.  Myths such as masturbation causing harm or women having 
sex or swimming during menstruation leading to negative outcomes and detrimental 
effects on one’s livelihood can stimulate erotophobic attitudes in individuals. According 
to Evans (2000), these myths can be unintentionally substantiated by erotophobic 
clinicians who avoid discussing sexually related concerns with clients and patients, a 
term noted by Evans as institutional erotophobia.  Institutional erotophobia combined 
with individual erotophobia may theoretically provide one explanation for the low 
prevalence of PGAD cases reported to date, particularly when stigma is factored in.   
 Stigma, specifically with respect to sexually related illness, or perceived sexually 
related illness such as PGAD, can have ubiquitous influence on individuals inflicted with 
these disorders. In a study on the prevalence of sexual dysfunction in a population of 417 
male and female teachers, Adegunloye and Gwabachi Ezeoke (2011) found that 53% of 
respondents who had indicated they had some form of sexual dysfunction (i.e. painful 
sex, female orgasm disorder, low or no desire, premature ejaculation) did not seek 
treatment.  Of those 53%, fear of stigma accounted for 26% of the reasoning for not 
seeking treatment.  Smith and Nave (2007) indicated social rejection scores of 
erotophobes towards fictitious patients with sexually transmitted infections were higher 
in their study than those of fictitious patients with non-sexually transmitted illnesses. 
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These stigmas not only contribute to social rejection, but have also been shown to 
contribute to depression, anxiety, and stress among people suffering from sexually related 
illness (Smith & Nave, 2007; Fife & Wright, 2000; Barth, et al., 2002; Crandall & 
Moriarty, 1995) and sexual dysfunction.   
 Manifestation of erotophobia in sexually related illness or perceived sexually 
related illness such as PGAD has been noted in the literature. Bergeron, Rosen and Morin 
(2011) referenced a randomized vestibulodynia (pelvic pain) treatment trial whereby 
level of erotophobia contributed to 27% of surgical outcome variance.  Women who were 
more erotophobic, based on their results of the Sexual Opinion Survey, responded less 
favorably to vestibular surgery than women who were less erotophobic. The researchers 
suggested that erotophobic beliefs could ultimately contribute to continuance of pain 
behavior and avoidance of sex even after pathophysiologic symptoms had been addressed 
(Bergeron, Khalife, Glazer & Binik, 2008).  Other researchers such as Lucena, 
Mukhopadhyay and Morris (2015) concurred with the recognition of erotophobic 
manifestation in sexually related illness, noting that high levels of erotophobia have also 
been found in women with dyspareunia (pain with intercourse).  Manifestations such as 
these provide the foundation and reasoning for the hypothesis that erotophobia could be a 
predictor or moderator in cases of PGAD.  For example, women with erotophobic 
dispositions might experience genital sensations as suggestive that they are somehow 
“dirty” or “shameful”, contributing to a state of anxiety and / or distress.  Erotophilic 
individuals may experience the same level of genital throbbing or fullness but experience 
it cognitively as either a neutral or even mildly pleasurable sensation. 
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Social Support System 
Social support, and more specifically partner support, is an important factor to 
consider when discussing predictors, correlates, moderators and mediators of the ever-
increasing abundance of illnesses faced today.  Peloquin, Bigras, Brassard and Godbout 
(2014) emphasized the importance of recognizing partner support as crucial with respect 
to the role it plays in both sexual health and overall well-being. These researchers, in 
particular, examined whether the perception of partner support would be a protective 
factor in correlations between psychosexual adjustment and several aspects of sexuality, 
including assertiveness, anxiety, avoidance, self-esteem under the realm of attachment 
theory.  Their findings noted that people with high attachment avoidance levels exhibited 
more erotophobic reactions to sexually related stimuli and were more uncomfortable 
regarding sexually related partner interactions than those with lower attachment 
avoidance levels. Early research by Dewitte (2012) noted similar findings, as did that of 
Girme, Overall, Simpson and Fletcher (2015) who indicated that those with high 
attachment avoidance can react defensively when approached with partner support.  
Interestingly, Peloquin et al. (2014) also noted that, in those with high attachment 
avoidance levels, sexual anxiety was higher when partner support was perceived as high.  
The researchers speculated that when partner support was perceived as high in high 
attachment avoidance individuals, poor psychosexual adjustment was amplified, perhaps 
elucidated by the intensified discomfort level of closeness and intimacy in these 
individuals. This concurred with Girme et al. assessment above regarding the potential 
for high avoidance individuals to react negatively to partner support. Brock and 
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Lawrence (2014; 2009) went one step further, first by acknowledging that not all support 
is adequate support, and second by defining two dimensions of inadequate partner 
support:  underprovision, or lack of adequate support and overprovision, or too much 
support. Subsequently, they indicated that perceived overprovision of the wrong kind of 
partner support, such as too much advice, can actually be more detrimental to a 
relationship than perceived underprovision of support.  This is perhaps due to the 
imbalance of support level each partner requires, meaning, for example that the receiving 
partner may not respond favorably to an “overdose” of support and experience it as 
psychologically or emotionally unsettling.  
In further research, Peloquin, Brassard, Lafontaine and Shaver (2014) noted that 
partner support provided, whereby the partner attempted to solve all the problems and 
minimized the opportunity for the affected partner to solve problems, correlated to lower 
sexual satisfaction in women.  This coincided with Brock’s and Lawrence’s (2014) 
research above regarding the relationship of overprovisioning and satisfaction.   
Other researchers, however, held contrary views.  Simpson, Winterheld, Rholes 
and Orina (2007) supported the notion that for some high attachment avoidant 
individuals, partner support is well-received and meritoriously calms the recipient, 
particularly when the level of support is high.  Rholes et al. (2011) similarly concluded 
that high levels of support in high attachment individuals ultimately brought about less 
depressive symptoms. 
Low avoidance individuals tend to receive all levels of support in a positive, 
accepting manner (Girme et al., 2015; Collins & Feeney, 2004).  This population tends to 
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harbor more trust in partner support and are less likely to ascertain the level of support 
equates to level of acceptance or rejection.  Interestingly, Bolger and Amarel (2007) as 
well as Gleason, Iida, Shrout and Bolder (2008) have suggested that high levels of partner 
support may actually interfere with resilience in low avoidance individuals by 
challenging their coping competencies.   
Researchers such as Bergeron, Rosen and Morin (2011) pointed out that in genital 
related disorders such as dyspareunia and vaginismus, relationship support and response 
are often ignored.  Research can be more readily found regarding partner support in 
illnesses such as cancer.  Sawin (2012) described the experiences of non-supportive 
partner relationships in older women with breast cancer, indicating that silence and 
shutting down was prevalent in the relationship, acting as defense mechanisms for both 
relationship participants.  Kinsinger, Laurenceau, Carver and Antoni (2011), in their 
study of perceived partner support in breast cancer patients, indicated that women who 
perceived their partner to be exhibiting supportive behaviors were more positively 
influenced with respect to relationship satisfaction and sexual adjustment.  As these 
researchers point out, perceived support has been shown to play a vital role in 
relationships inflicted with illness and therefore should be examined more closely by 
researchers across a myriad of fields of study. 
Summary 
Persistent genital arousal disorder has become a matter of discussion among 
clinicians and researchers within the past two decades.  Sandra Leiblum was a pioneer in 
bringing the disorder to our attention and shedding light on its distressing symptoms 
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(Leiblum & Nathan, 2001).  Over the past few years, other researchers have continued 
the quest to uncover the pathology underlying the disorder.  Those such as Graziottin 
(2004), Goldmeier and Leiblum (2008), Bedell et al. (2014), Leiblum et al. (2005), 
Komisarik and Lee (2014), Eibye and Jensen (2014), and Pink, Rancourt and Gordon 
(2014) have unearthed a broad potential of etiologies such as Tarlov Cysts,  pelvic 
varices, neural concerns, psychological factors, or previous SSRI/SNRI use.  Waldinger 
et al. (2010, 2009) expanded the etiological theories to suggest PGAD may be part of a 
grouping of symptoms they collectively deem restless genital syndrome.  Treatments 
currently remain limited, emphasizing the importance of further research needed on the 
disorder. 
With so little research available on PGAD, the gaps in the literature remain large.  
Psychological factors have been considered, including the premise that anxiety may play 
a role; however, the literature remains deprived of significant psychological predictors 
and moderators of PGAD.  Two of the more puzzling questions that remain regarding 
PGAD center on causality and nature of the distress that women experience.  A number 
of hypotheses regarding potential causality have been generated, including Tarlov cysts, 
pelvic congestion, restless leg/genital syndrome and pudendal neuropathy.   
Chapter 2 illustrated the small amount of empirical support available for these 
hypotheses.  Of note however, most of these have been based on case-reports or post-hoc 
analyses of small samples.  No one has yet attempted to ascertain utilizing open-ended 
items to determine what, if anything, women with PGAD associate with its development / 
onset.   Regarding distress, it is important to note there are no valid, reliable instruments 
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that have been developed to specifically address the distress that women with PGAD 
experience, leaving researchers with an imperfect understanding of this important 
phenomenon.   
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Chapter 3: Research Method 
Introduction 
The purpose of this study was to provide a broader understanding of significant 
psychological correlates of distress in women with PGAD, specifically the potential 
contribution of depression, anxiety, and stress, as well as the impact of erotophobia-
erotophilia and the nature of perceived partner support as moderators. In this chapter, I 
explain the methodology and procedural approach that I used in the study.  Research 
design, rationale for the design, sampling procedures, instrumentation and operational 
procedures will also be illuminated.  
Research Design and Rationale 
PGAD is still in the early stages of discovery and understanding.  Little is known 
about the pathology of this disorder, or why some women have higher distress levels than 
others.  Psychological factors have been implicated as possible etiologies in prior 
research; however, no formal studies have been done to hone in on psychological 
contributors to distress, and there is no clear clinical understanding of what factors might 
modulate the distress.  My goal in this study was to do just that: examine the role of three 
psychological correlates (depression, anxiety, stress) on levels of distress and the 
potential for erotophobia-erotophilia or positive/negative levels of perceived partner 
support to moderate those levels of distress. 
A quantitative, cross-sectional, correlational, non-experimental, survey 
methodological approach was used with a convenience sample of women with PGAD.  I 
recruited the participants from those individuals who have sought consultation and/or 
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treatment from San Diego Sexual Medicine (SDSM) in San Diego, California, and from 
an online Facebook PGAD support group. I chose the clinical site because of its stellar 
reputation as a major sexual health clinic, along with its history of working with women 
who have PGAD and the willingness of the staff to work with up and coming researchers 
in the field of sexual health.  I chose the online support group as a means to recruit an 
adequate number of women with PGAD, considering the small population who report the 
disorder.  The addition of the support group increased the potential for recruiting women 
who had not yet sought treatment for PGAD, thereby increasing heterogeneity and 
reducing bias towards women who have sought treatment.  
As previously noted the quantitative approach allows for the analysis of numerical 
variables captured via instruments such as survey questionnaires and allows for the 
utilization of appropriate statistical procedures and reporting.  Correlational methodology 
provides for the measurement of predictability and relationships among variables; 
however, this method should not be confused with causal relationships (Creswell, 2008).  
Using a cross-sectional survey design allows for the collection of data at a given time 
point in a more economical and timely manner than a longitudinal framework (Creswell, 
2014).  With so little research currently available on PGAD, I determined that a cross-
sectional study with previously unstudied moderator variables could provide a significant 





The dissertation study recruited female participants meeting the five criteria for 
PGAD from two sources: the office of Dr. Irwin Goldstein at SDSM in San Diego, 
California, and an online private Facebook PGAD Support Group for Men and 
Women.  While the women I recruited from SDSM had sought consultation and/or 
treatment from SDSM, they may physically be located throughout the globe, as are the 
women in the support group.  Because this disorder is currently considered rare, 
potentially due to underreporting, the target population was low.   
SDSM, which opened its doors in 2007, collects a variety of demographic data 
for their patients, including email addresses.  Patients have agreed to contact from 
SDSM via email.  Aggregated patient records from this institution indicate that 
approximately 250 (+/- 5%) adult women are receiving or have received treatment or 
advice for PGAD from Dr. Goldstein since 2007 and continue to suffer from PGAD.  I 
recruited 50 women meeting the inclusion criteria from the SDSM convenience 
sample via targeted emails by site staff.  To keep the identities of participants 
confidential, I provided the study site with a letter (see Appendix B) along with the 
survey link to send to potential participants via email requesting their voluntary 
participation in the online study.  I had no access to any medical charts.  Once recruited 
into the study, participants completed a series of self-report questionnaires via Survey 
Monkey, an online survey center.  A reminder/follow-up email was sent to potential 
participants 7 days after the original email thanking those who already completed the 
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survey and reminding those who had not to please consider participating, followed by a 
final reminder at day 14. 
For the participants in the online Facebook PGAD support group consisting of 
131 female participants at the time of the study, I provided, via an online posting to the 
group, an invitation for survey participation (see Appendix C), an explanation of what 
the survey is and who may be eligible, and a link to the survey, including the informed 
consent.  A reminder/follow-up post regarding voluntary participation was posted in the 
support group 7 days after the original email, followed by a second/final reminder 14 
days after the original post. 
Sampling 
To determine the statistically appropriate sample size, I conducted a power 
analysis using G*Power 3.1 statistical software (see Faul et al., 2009).  A medium effect 
size (0.30) was considered to be appropriate under the rationale that there was little 
empirical research to guide me to the ultimate effect size I should have been aiming for. 
Using the Test Family setting in G*Power of t-tests, and the Type of Analysis set to a 
priori, an effect size of 0.30, and a conventional alpha level of .05, the G*Power 
calculator, with power of .80, indicated a required sample size 64.  I chose this method 
over others such as prediction models (e.g. logistic regression) because the underlying 
function of the study was to detect correlations in PGAD and anxiety, depression, and 
stress with erotophobia-erotophilia and perceived partner support as moderators of these 
factors, and it was not to predict these factors as a cause or result of PGAD. 
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Data Collection Process 
 I collected data from participants via an email/posted link to an online survey 
located on the Survey Monkey website.  The survey consisted of multiple questionnaires 
including: the FSDS-R (Deragotis et al. 2008; Fisher et al., 2013), the DASS-21 (Henry 
& Crawford, 2005), the Sexual Opinion survey (Davis, Yarber, Bauserman, Schreer, & 
Davis, 1998; Fisher, et. al, 1988), and the Actually Received Support, a subscale of the 
Berlin Social Support Scales (Schulz & Schwarzer, 2003), as well as a questionnaire that 
eliciting demographic and gynecological information. 
 The format of the survey was as follows: (a) an invitation to participate in the 
survey, (b) an explanation of the survey’s purpose, (c) a description of what the survey 
entailed, (d) an explanation of the voluntary nature of the study and the risks and benefits 
of participation, (e) a confidentiality statement, (f) my contact information should any 
questions or concerns have arisen, (g) informed consent, and (h) a description of 
inclusion and exclusion criteria.  These items were followed by a collection of 
demographic information including age, race, education, relationship status, income 
level, religion, spirituality, and sexual orientation. The following gynecological/medical 
questions were collected to assess their prevalence in women with PGAD for notation 
of potential biological pathology, as I noted in Chapter 1: pre- or post-menopausal, 
number of pregnancies, number of children, method of childbirth, history of overactive 
bladder (a yes/no question), history of restless leg syndrome (a yes/no question), history 
of Tarlov cysts (a yes/no question), history of pudendal neuropathy (a yes/no question), 
and history of sexually transmitted infections (a yes/no question).  I collected history of 
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SSRI and SNRI use, asking if these were taken “currently” and/or “in the past.”  Length 
of time the participant had PGAD symptoms and exploratory distress and 
embarrassment levels was collected, along with whether or not the participant had seen 
a healthcare provide regarding PGAD symptoms, how satisfied they were with the care 
received, and if they related their symptoms to any specific event. 
 The remaining items included all questionnaires mentioned above.  The order of 
flow was as follows: 
1. The FSDS-R. 
2. The DASS-21. 
3. The Sexual Opinion Survey. 
4. The Actually Received Support subscale. 
The final items at the end of the survey were two open-ended questions including: 
1. Please describe in detail how PGAD has affected your life. 
2. What aspects of PGAD do you feel contribute most to your distress? 
Inclusion criteria included: 
1. Women age 18 and over who meet criteria for PGAD defined as the following 
(Waldinger & Schweitzer, 2008): 
a. Involuntary genital arousal that persists for an extended period of time. 
b. The arousal does not dissipate upon orgasm.  
c. The arousal is not related to sexual desire. 
d. The arousal is intrusive and unwanted.  
e. The arousal is distressful and / or bothersome. 
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2. PGAD has been present for minimum of six months. 
3. Ability to read, understand and provide informed consent. 
Exclusion criteria included: 
1. Inability to read and understand English. 
Instrumentation and Operational Constructs 
Dependent Variable –Distress 
 Distress associated with PGAD, the dependent variable, was measured using the 
FSDS-R (Deragotis et al., 2008; Fisher et al., 2013). This is due in part to the lack of an 
available PGAD distress scale.  The FSDS-R is a validated 13-item, Likert-type 
questionnaire with responses ranging from 0 (Never) to 4 (Always), with higher scores 
equating to higher distress.  An example from the questionnaire is: “How often did you 
feel guilty about your sexual difficulties?”  Test-retest reliability for the FSDS-R showed 
greater than 0.74 for the intraclass correlation coefficient, and Cronbach’s alpha of 
greater than 0.86 for internal consistency (Derogatis, et al., 2008).  A copy of the scale 
can be found in Appendix A. 
Independent Variables – Depression, Anxiety, and Stress 
 I assessed independent variables using a multilinear regression analysis.  These 
variables included depression, anxiety, and stress, and I measured them using the 
validated, 21-item Likert-type DASS-21 (Henry & Crawford, 2005).  Responses range 
from 0 (Never) to 3 (Almost Always) and provided a separate score for each of the three 
factors under study.  Scores indicate Normal, Mild, Moderate, Severe, or Extremely 
Severe levels of depression, anxiety, and stress. An example of a question is: “I found it 
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hard to wind down.”  Reliability for this instrument, using Cronbach’s alpha, is .88 for 
the Depression scale items, .82 for the Anxiety scale items, and .90 for the Stress scale 
items (Henry & Crawford, 2005).  A copy of the scale can be found Appendix A. 
Moderating Variables – Erotophobia/Erotophilia and Perceived Partner Support 
 I used moderation analysis to test the effects of the level of erotophobia-
erotophilia and the nature of perceived partner support in women with a partner as 
moderating variables.  A Mann-Whitney test was conducted to compare women with 
partners and women without.  Assessment involved the determination of any increase or 
decrease in the established effects of depression, anxiety, and stress on PGAD distress.  
The Sexual Opinion Survey (SOS), a validated 21-item Likert-type scale with acceptable 
test-retest reliability with Cronbach’s alpha of 0.90 (Davis, Yarber, Bauserman, Schreer, 
& Davis, 1998; Fisher et. al, 1988; Gilbert & Gamache, 1984) was the instrument I used 
to assess erotophobia-erotophilia. An example question is: “If people thought I was 
interested in oral sex I would be embarrassed.”  Responses range from Strongly Agree to 
Strongly Disagree. Negative (low) scores demonstrate erotophobia, while positive (high) 
scores demonstrate erotophilia.  Scores for the SOS range from 0-126 upon calculation, 
using the addition of + 67 in the scoring method to eliminate negative scores for 
simplification of scoring interpretation by keeping all scores positive (see Fisher et al., 
1988).  A copy of the scale can be found Appendix A. 
 I used the Actually Received Support, a Likert-type 14-item subscale of the Berlin 
Social Support Scales to examine the nature of perceived partner support for women with 
a partner (Schulz & Schwarzer, 2003).  This scale was skipped for those women who did 
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not have a partner. An example of a question on the scale is: “The person comforted me 
when I was feeling bad.”  Responses range from 1 (Strongly Disagree) to 4 (Strongly 
Agree).  The scale consists of both positive (11) and negative (3) questions, resulting in 
negative question scores having to be reversed for questions 3, 4, and 5.  Higher scores 
demonstrate positive support received, while lower scores demonstrate less or lack of 
positive support.  Reliability and validity have been established in several studies, 
indicating a Cronbach’s alpha for internal consistency and reliability of .83 (Schulz & 
Schwarzer, 2003). A copy of the scale can be found Appendix A. 
Summary of Scales 
 I chose the scales listed above based on their validity and extensive use in 
research.  The length of each scale is adequate for sufficient data capture while short 
enough to keep survey fatigue at a minimum and encourage full completion by 
participants.  All scale items combined equate to 69 questions, in addition to 
demographic, gynecological information and open-ended questions. 
Demographics and Gynecological Information 
 Each participant was requested to complete demographic and gynecological 
information in order to categorize participants and capture prevalence of these variables 
among women with PGAD. Descriptive tables are presented in chapter 4 to show how 
many women fall into each of the categories. 
Open-ended Questions 
Although I used a validated measure of sexually-related distress in this study, its 
use does not suggest that sexually-related distress is the only, or even the most salient, 
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aspect of the personal distress these women experience.  In order to generate possible 
themes for hypothesis generation I asked a total of three open-ended questions in the 
survey, including: 
o If participant answered “yes” to association of PGAD with a specific 
event, please specify event.  
o Please describe in detail how PGAD has affected your life.  
o What aspects of PGAD do you feel contribute most to your distress?    
  A significant number of comments were provided by the participants.  I did not 
conduct a thematic analysis on these comments in this dissertation. These questions were 
intended for information gathering items to be coded and analyzed in future qualitative 
publications.  Samples of comments with minimal discussion are presented later in this 
dissertation to be used as illustrative reference points for discussion in chapter 5.    
Research Questions, Hypotheses, and Statistical Analysis Methodology 
Data Screening and Cleaning 
 I collected and retrieved data by export from SurveyMonkey.com.  I performed 
statistical analysis using SPSS version 21.  Statistical significance was based on an alpha 
level of .05.  I performed an analysis to determine the degree of missing data. For 
questionnaires, no data points were present where less than 5% of the data were missing; 
therefore, eliminating the need for imputation of the mean.  
 I analyzed several items study including whether or not anxiety, stress, and/or 
depression are significant correlates of distress; which of these three psychological 
factors proved to have the strongest relation to distress; and if the relationship between 
56 
 
the level of PGAD distress and anxiety, stress and/or depression was moderated by level 
of erotophobia-erotophilia and/or the nature of perceived partner support.   
Research Questions and Hypothesis 
Research Question 1.  Will anxiety be the strongest predictor of distress among 
the following three predictors: anxiety, stress, or depression? 
H01: Anxiety will not account for the most variance of the three predictors of 
distress in women with PGAD. 
H11: Anxiety will account for the most variance of the three predictors of distress 
in women with PGAD. 
Analysis:  To analyze whether or not anxiety, stress, and/or depression are significant 
correlates of distress in women with PGAD, a hierarchical multiple linear regression 
analysis was utilized (Frankfort-Nachmias & Nachmias, 2008). Assumptions for this test 
include normal distribution in the population and a random sample of observations drawn 
from the population of women with PGAD with variable scores independent of other 
scores on the same variables.  This test was utilized because there are more than three 
variables involved, with distress being the dependent variable and all others being 
independent variables.     
Research Question 2.  Does erotophobia-erotophilia moderate the relationship 
between the strongest predictor (anxiety, stress, or depression) and level of distress? 
H02: Level of erotophobia-erotophilia will not moderate the relationship between 
the most significant predictor and level of distress in women with PGAD. 
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H12:  Level of erotophobia-erotophilia will moderate the relationship between the 
most significant predictor and level of distress in women with PGAD. 
Analysis:  To analyze whether the relationship of distress in women with PGAD and 
anxiety, stress and/or depression is moderated by level of erotophobia-erotophilia, a 
multiple regression analysis was utilized under the assumption of normal distribution in 
the population.  Holmbeck (1997) indicates this test is optimal for testing moderated 
effects on continuous variables and is specifically designed to test the degree of linear 
relationship between predictor and moderator variables that may or may not exist in a 
sample using quantitative variables.   
Research Questions 3.  Does the nature of perceived partner support moderate the 
relationship between the strongest predictor (anxiety, stress, or depression) and level of 
distress for PGAD women with partners? 
H03: Nature of perceived partner support will not moderate the relationship 
between the most significant predictor and level of distress in women with PGAD. 
H13:  Nature of perceived partner support will moderate the relationship between 
the most significant predictor and level of distress in women with PGAD. 
Analysis:  To analyze whether the relationship of distress in women with PGAD and 
anxiety, stress and/or depression is moderated by the nature of perceived partner support, 
a multiple regression analysis (Field, 2013) was performed to assess the contribution of 




Research Questions 4.  Is there a difference in distress levels for PGAD women 
with partners compared to PGAD women without partners? 
H04: Level of distress will not be different for PGAD women without partners 
than for PGAD women with partners. 
H14: Level of distress will be different for PGAD women without partners than 
for PGAD women with partners. 
Analysis:  To analyze whether PGAD women with partners will have different levels of 
distress than PGAD women without partners, a one-way ANOVA was conducted to 
compare the two groups. 
Threats to Validity 
 Due to the cross-sectional approach to the study, external validity is limited with 
respect to generalizing from the study sample to the population.  As a convenience 
sample was used, limitations of reflecting the overall PGAD population are a 
consideration.  Due to the nature of the study, reluctance to answer sensitive questions 
could have contributed to missing information and small sample size.  No conclusions 
regarding cause and effect can be presumed from this study. 
Ethical Considerations 
 I sought and obtained IRB approval prior to study initiation.  The IRB approval 
number is 02-22-16-0023616.  Each participant was provided an online informed consent 
form when they clicked on the link to the study. This form included an explanation of the 
nature of the study, the risks and benefits associated with study participation, a 
confidentiality statement, a statement of consent and age verification, and contact 
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information of the researcher.  Each participant was made aware of their voluntary 
participation and that they could have withdrawn from the study at any time without 
consequence simply by closing and submitting the survey either completed or 
incomplete.  Participants were made aware that no follow-up to the survey is required. 
Personal monetary rewards were not provided for study participation.   
 The identity of the participants remained confidential.  Email addresses were 
maintained by the clinical site and only the primary researcher had additional email 
access. I obtained no identifying information (e.g. name, address, birth date).  Potential 
risks of the study included those associated with negative emotions and experiences 
based on the sensitive nature of the study.  I provided links to informational resources 
regarding depression and anxiety (http://www.apa.org/helpcenter/understanding-
depression.aspx and http://www.apa.org/topics/anxiety/index.aspx) to participants at the 
end of the study and encouraged participants to call their primary care physician if they 
became distressed upon taking the survey.  I had no conflicts of interest in conducting 
this study. 
Summary 
 In chapter 3, I provided an outline of the research design and methodology 
for the study of sexual distress in women with PGAD.  Sample selection strategy, data 
collection, instrumentation tools, and analysis procedures were defined, including 
justifications and assumptions.  I provided research questions and hypotheses along with 
how each was analyzed.  Finally, I described inclusion and exclusion criteria, examined 
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ethical considerations, and provided a notation of where all items (instruments and 
informed consent) can be found.   
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Chapter 4: Results  
Introduction 
This chapter contains the results of the data analyses of the completed surveys.  
The purpose of the study was to examine predictors (anxiety, depression, stress) and 
moderators (erotophobia-erotophilia and partner support) of distress in women with 
PGAD.  I examined (a) whether or not anxiety would be the strongest predictor, (b) 
whether or not erotophobia-erotophilia moderated the relationship between the strongest 
predictor and the level of PGAD distress, (c) whether or not the nature of perceived 
partner support moderated the relationship between the strongest predictor and the level 
of distress in women with PGAD, and (d) whether or not there is a difference in distress 
levels for women with PGAD with partners compared to women with PGAD without 
partners. 
Participant Demographic and Medical Information 
Seventy-three female participants agreed to participate in the online survey. Of 
the 73 responses received, 22 were excluded because of not meeting all five criteria for 
PGAD.  Of the 51 remaining participants, 21 (41.2%) were clients of SDSM, while 30 
(58.8%) were participants of an online PGAD support group.  Response rates were 42% 
(22 out of 50) for the SDSM group, and 22.9% (30 out of 131) for the online support 
group.  I conducted a one-way ANOVA on the dependent variable (FSDS-R scores) to 
compare the two groups of respondents from SDSM and the online support group.  The 
ANOVA was not statistically significant, F(1,49) = .577, p = .45,  indicating no 
significant difference between the two groups with respect to the dependent variable; 
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therefore, the groups were combined for analysis of the research questions.  Similarly, I 
conducted ANOVAs on the independent variables of anxiety scores, depression scores, 
and stress scores to compare the two groups of respondents from SDSM and the online 
support group.  All three ANOVAs were not statistically significant [F(1,50) = .266, p = 
.814; F(1,50) = .056, p = .608; F(1,50) = 2.66, p = .109, respectively], indicating no 
significant difference between the two groups on these parameters. 
The majority of participants (88.2%) were located in the United States, while the 
remaining participants (11.8%) were from Europe (i.e., England, Finland, Germany, 
Slovakia, and Sweden).  The age range of the participants was from 21-years to 74-years 
old, with a mean age of 47 (SD = 13.37).  The average amount of time respondents had 
had PGAD was 106 months, with the minimum number at 5 months and the maximum at 
480 months (40 years).   
No statistically significant correlation appeared between age and FSDS-R score (p 
= .76), as shown in Table 2.  Similarly, a Pearson correlation was computed on duration 
of PGAD and FSDS-R score, and the result was not statistically significant (p = .68). 
Participants reported varied backgrounds with regards to education, religion, 
spirituality, and sexuality.  Table 1 illustrates the variability in responses.  The majority 
of participants were either married (62.7%) or in a relationship living with a partner 
(7.8%), for a combined total of 70.5%.  Approximately half of the participants indicated 
working full- or part-time (27.5% and 21.6% respectively, for a combined total of 
49.1%).  Income levels were also varied, ranging from less than $25,000 (8%) to greater 
than 100,000 (14%).  The majority of participants were either exclusively or 
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predominantly heterosexual both with respect to behavior (98%) and fantasy (84.3%) 
over the course of their lifetime.  
Table 1 
Demographic Characteristics of Study Sample   
Demographic N % 
Association   
   San Diego Sexual Medicine 21 41.2 
   FacebookTM online support group 30 58.8 
Race   
   Caucasian 47 92.2 
   Black or African-American 2 3.9 
   Multiracial 1 2.0 
   Other 1 2.0 
Education   
   High School Diploma 11 21.6 
   Associate’s Degree 7 13.7 
   Bachelor’s Degree 13 25.5 
   Master’s Degree 9 17.6 
   Doctorate Degree 4 7.8 
   Other 7 13.7 
Religious Affiliation   
   Christian 27 52.9 
    Jewish 2 3.9 
   Atheist / Agnostic 6 11.8 
   No religious affiliation 10 19.6 





Demographic N % 
Spirituality   
   Not at all Spiritual 4 7.8 
   Slightly Spiritual 9 17.6 
   Somewhat Spiritual 12 23.5 
   Quite Spiritual 18 35.3 
   Extremely Spiritual 8 15.7 
Employment    
   Full time employed 14 27.5 
   Part time employed 11 21.6 
   Student 2 3.9 
   Retired 7 13.7 
   Non-employed 17 33.3 
Household Income   
   <$25,000 8 15.7 
   $25,001 to 50,000 10 19.6 
   $50,001 to 75,000 7 13.7 
   $75,001 to 100,000 11 21.6 
   >$100,000 14 27.5 
   Did not respond 1 2.0 
Relationship Status   
   Single 8 15.7 
   Married 32 62.7 
   Separated 1 2.0 
   Divorced 6 11.8 





Demographic N % 
Sexuality – Kinsey Scale -Fantasy    
   Exclusively heterosexual 23 45.1 
   Predominantly heterosexual, rare homosexual 20 39.2 
   Predominantly heterosexual, more than rare   homosexual 3 5.9 
   Equally heterosexual/homosexual 3 5.9 
   Predominantly homosexual, more than rare heterosexual 1 2.0 
   Predominantly homosexual, rare heterosexual 1 2.0 
   Exclusively homosexual 0 0.0 
Sexuality – Kinsey Scale - Behavior   
   Exclusively heterosexual 35 68.6 
   Predominantly heterosexual, rare homosexual 15 29.4 
   Predominantly heterosexual, more than rare homosexual 1 2.0 
   Equally heterosexual/homosexual 0 0.0 
   Predominantly homosexual, more than rare heterosexual 0 0.0 
   Predominantly homosexual, rare heterosexual 0 0.0 
   Exclusively homosexual 0 0.0 







Correlation Between Study Variables and Distress 
Measure FSDS-R 
FSDS-R1  
Age                              -.04 
Duration of PGAD2                                .06 
Religion                                .20 
Spirituality                                .13 
Sexuality-fantasy                                .13 
Sexuality-behavior                                .20 
No. of Medical Diagnoses                                .36** 
No. of Pregnancies                                .35* 
No. of Births                                .25 
Depression                                .51** 
Anxiety                                .28* 
Stress                                .25 
Sexual Opinion Survey                                .00 
Partner Support                                .07 





I conducted bivariate correlations between sexual distress and the following 
demographic variables: age, religiosity, spirituality, sexual fantasy, sexual behavior, 
erotophobia-erotophilia, and partner support (see Table 2).  None of these variables were 
found to have a correlation with sexual distress measured by the FSDS-R.  Bivariate 
correlations were also conducted on sexual distress and medical diagnoses and 
gynecological history variables including total number of medical diagnoses, number of 
pregnancies and number of births (see Table 2).  Total number of medical diagnoses and 
number of pregnancies were the only variables found to have a significant correlation 
with sexual distress measured by the FSDS-R.  Pearson correlations were computed 
between erotophobia-erotophilia and FSDS-R, as well as partner support and FSDS-R.  
No statistically significant correlations were found between sexual distress measured by 
the FSDS-R and perceived partner support or the SOS (see Table 2).   
Using sexual distress as the dependent variable, I conducted a series of ANOVAs 
on other demographic variables including race, F(3, 47) = 1.44, p = .244; education, F(5, 
45) = .47, p = .794; employment, F(4, 46) = 5.15, p = .002; income, F(4, 45) = 1.25, p = 
.304; and religion, F(4, 46) = .552, p=.699; as well as on the nominal gynecological 
variable menopausal status, F(3, 47) = .634, p = .597.  Employment status was the only 
variable of these to have a relationship to distress measured by the FSDS-R.  Follow-up 
tests were conducted on employment status to evaluate the pairwise differences among 
the means. Dunnett’s C test was used, a test that does not assume equal variances, due to 
the small sample size (Green & Salkind, 2011).  There was a significant difference in the 
means between part-time employed and the non-employed groups, but no significant 
68 
 
differences between the others.  The non-employed group showed higher FSDS-R scores 
compared to the part-time employed group (see Table 3).  Similarly, an ANOVA 
conducted on the non-employed group showed higher scores on all three subsets of the 
DASS-21 psychological measurements (depression, anxiety, and stress).  
Table 3 
Employment Descriptives 
Employment Status M1 – FSDS-R M – Depression M – Anxiety M – Stress 
Full-time 35.57 6.14 4.50 9.79 
Part-time 28.73 9.09 8.09 13.18 
Student 45.00 14.00 4.00 14.50 
Retired 37.71 5.57 5.00 9.29 
Non-employed 48.47 14.53 10.82 15.24 
1M = mean 
Frequencies of medical diagnoses and gynecological history were performed and 
presented in Table 4.  Several respondents reported more than one medical diagnosis 

















 N % 
Ever been diagnosed with?   
  Overactive Bladder 15 29.4 
  Restless Leg Syndrome  12 23.5 
  Tarlov Cysts 4 7.8 
  Pelvic Congestion Syndrome 2 3.9 
  Pudendal Neuropathy 16 31.4 
  Sexually Transmitted Infection 16 31.4 
Number of diagnoses from above   
  0 15 29.4 
  1 16 31.4 
  2 11 21.6 
  3 9 17.6 
Gynecological History 
Menopausal Status   
   Pre-menopausal 16 31.4 
   Peri-menopausal 9 17.6 
   Post-menopausal 21 41.2 





 N % 
Number of Pregnancies   
   0 16 31.4 
   1 7 13.7 
   2 11 21.6 
   3 8 15.7 
   4 or more 9 17.6 
Number of Births   
   0 19 37.3 
   1 10 19.6 
   2 11 21.6 
   3 5 9.8 
   4 or more 6 11.8 
Method of Birth   
   Vaginal 20 39.2 
   C-Section 7 13.7 
   Both 5 9.8 
   Not Applicable 19 37.3 




Antidepressant medication (SSRIs and others) use was assessed for current use, 
past use, and both.  Of the 51 participants, 40 reported they had taken an SSRI or other 
antidepressant in the past, while 22 were currently taking at least one of these 
medications, and 18 indicated both current and past use (Table 5). 
 
Table 5 
SSRI and other Antidepressant Use 
Use of medication N % 
Current use  22 43.1 
Past use 40 78.4 
Both current and past use 18 35.3 
   
 
A majority of the women (58.8%) who participated in the study indicated they 
have seen four or more healthcare providers regarding their PGAD symptoms, with less 
than one-third (27.4%) indicating they are at least somewhat satisfied with the support 
they have received from their providers.  In response to a non-validated question 
inquiring about PGAD symptom distress over the past six months, the majority of 
respondents indicated they were quite or extremely distressed (84.3% combined total).  
Participants also indicated they were at least somewhat embarrassed about their PGAD 
symptoms (somewhat = 23.5%; quite = 19%, extremely = 9%).  Almost two-thirds of the 
participants (62.8%) associated the onset of their PGAD symptoms with a specific event 
(i.e. – SSRI or other medication use, pregnancy, hysterectomy).    
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Predictors of Sexual Distress 
Hypotheses – Research Question 1 
 The null and alternative hypotheses for Research Question 1 were as follows: 
Research Question 1.  Will anxiety be the strongest predictor of distress among 
the following three predictors: anxiety, stress, or depression? 
H01: Anxiety will not account for the most variance of the three predictors of 
distress in women with PGAD. 
H11: Anxiety will account for the most variance of the three predictors of distress 
in women with PGAD. 
  I conducted data analysis using the SPSS 21 software package.  Collinearity 
between the three predictor variables (anxiety, depression, stress) was assessed and 
confirmed based on the Variance Inflation Factor (VIF) statistics (anxiety: VIF = 2.38; 
depression: VIF = 2.51; stress: VIF = 2.87).   
 Simple bivariate correlations between anxiety, depression, and stress were 
computed using Pearson's r.  Statistically significant correlations occurred between 
anxiety and depression (r = .69, p < .01) and anxiety and stress (r = .73, p < .01), and 
stress and depression (r = .75, p < .01).  There were also statistically significant 
correlations between the stress and age (r = -.41, p < .05) as well as depression and age (r 
= -.35, p < .05).  Sexual distress measured by the FSDS-R was significantly correlated to 
depression (r = .51, p = .00) and anxiety (r = .28, p = .044). Stress (r = .25, p = .083) was 
not statistically significant in correlation computations to sexual distress measured by the 
FSDS-R. Mean scores for FSDS-R and subsections of the DASS-21 are shown in Table 
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6.  Mean scores for all three psychological factors fell within the moderate range of 
severity per DASS-21 scoring measures (Henry & Crawford, 2005). 
Table 6   
Means and Standard Deviations 
   
Measure Mean SD Possible Range  Obtained Range 
FSDS-R Distress1 25.24 14.53 0-52  0-52 
DASS2 Depression  9.80 5.82 0-21  0-21 
DASS Anxiety  7.43 7.96 0 -21  0-21 
DASS Stress  12.45 4.52 0-21  2-21 
Sexual Opinion Survey  61 21.64 0-126  0-97 
BSSS3 Partner Scale 48 10.00 15-60  18-60 
1Female Sexual Dysfunction Scale; 2Depression Anxiety Stress Scale; 3Berlin Social 
Support Scale. 
 
I conducted a hierarchical multiple regression analysis to determine the strongest 
significant predictor of sexual distress, if any.  I chose a hierarchical multiple regression 
based on research and theory in the literature that have demonstrated anxiety to be a 
significant contributor to distress in PGAD and also to allow for the possibility that 
anxiety is statistically not the best predictor (i.e. to allow for the opportunity to reject the 
hypothesis).  Depression and stress were put into block 1, while anxiety was put into 
block 2 to determine if it added to the prediction over and above the prior two variables. 
Preliminary analyses were performed to ensure there was no violation of the assumption 
of normality, linearity and multicollinearity. A statistically significant regression equation 
was found, F (2, 48) = 10.01, p < .01.   The R2 for step 1 was .30 as it was for step 2. 
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Anxiety was excluded from the equation (p = .97) while stress showed no statistical 
significance (p = .10), indicating that depression was the best and only statistically 
significant predictor of sexual distress measured by the FSDS-R, accounting for 30% of 
the variance, while anxiety did not contribute to the variance (Table 7).  Therefore, I 
failed to reject null hypothesis.   
Table 7  
Hierarchical Regression  
Step 1 b SE B β p R2 ΔR2 
Constant 32.46 5.24 -- < .01 .30 .27 
Depression 1.83 .46  .73  < .01 -- -- 
Stress -.98 .59 -.30 .10 -- -- 
Step 2       
Constant 32.50 5.41 -- .97 .30 .25 
Anxiety .02 .55 .01  .97 -- -- 
 
Moderators of Sexual Distress  
Hypotheses – Research Questions 2 and 3 
 The null and alternatives hypotheses for Research Question 2 The null and 
alternatives hypotheses for Research Question 2 were as follows: 
Research Question 2.  Does erotophobia-erotophilia moderate the relationship 
between the strongest predictor (anxiety, stress, or depression) and level of distress? 
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H02: Level of erotophobia-erotophilia will not moderate the relationship between 
the most significant predictor and level of distress in women with PGAD. 
H12:  Level of erotophobia-erotophilia will moderate the relationship between the 
most significant predictor and level of distress in women with PGAD. 
The null and alternatives hypotheses for Research Question 3 were as follows: 
Research Questions 3.  Does the nature of perceived partner support moderate the 
relationship between the strongest predictor (anxiety, stress, or depression) and level of 
distress for PGAD women with partners? 
H03: Nature of perceived partner support will not moderate the relationship 
between the most significant predictor and level of distress in women with PGAD. 
H13:  Nature of perceived partner support will moderate the relationship between 
the most significant predictor and level of distress in women with PGAD. 
I conducted a moderation analysis using the PROCESS feature created by Hayes 
(2012) for use in SPSS to assess if depression, the most significant predictor of sexual 
distress, would be moderated by erotophobia-erotophilia or by the nature of perceived 
partner support.  Fifty-one participants were again analyzed for the erotophobia-
erotophilia moderation and 38 participants (those who indicated they had partners and 
completed the Berlin Social Support – Actually Received Support scale (BSSS)) were 
analyzed for the perceived partner support moderation.      
 The moderation analysis revealed no statistically significant alteration in the 
variance accounted for when the interaction effect between the Sexual Opinion Survey 
scores and depression scores was computed (b = -0.001, 95% CI [-0.034, 0.032], t =         
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-0.45, p = .965).  The relationship between depression and sexual distress measured by 
the FSDS-R is not moderated by erotophobia-erotophilia (see Table 8).  Similarly, no 
statistically significant alteration in the variance was accounted for when the interaction 
effect was computed between the nature of perceived partner support and depression 
scores moderation analysis (b = -0.005, 95% CI [-0.079, 0.069], t = -0.15, p = .883).  The 
relationship between depression and sexual distress measured by the FSDS-R is not 
moderated by perceived partner support (see Table 9).  I failed to reject the null 
hypotheses for research questions 2 and 3. 
Table 8 
Moderation Analysis of Erotophobia-Erotophilia 
 b se t P LLCI2 ULCI3 
constant 38.224 1.90 20.14 0.00 34.42 42.05 
SOS1 total score 0.005 0.10 0.05 0.96 -0.20 0.21 
Depression total score 1.263 0.33  3.81 0.00 0.60 1.93 
Interaction effect -0.007 .02 -0.45 0.96 -0.03 0.03 






Moderation Analysis of Partner Support 
  b se t p LLCI2 ULCI3 
constant 38.736 2.20 17.57 0.00 34.26 73.22 
BSSS Total Score1 -0.184 0.21 -0.88 0.39 -0.61 0.24 
Depression Total Score 1.307 0.41  3.21 0.00 0.48 2.13 
Int_1 -0.005 .04 -0.15 0.88 -0.08 0.69 
1Berlin Social Support Scales –Actually Received Support; 2Lower limit Confidence 
Interval; 3Upper limit Confidence Interval 
 
Women with Partners vs. Women without Partners 
Hypothesis – Research Question 4 
The null and alternative hypotheses for Research Question 4 were as follows: 
Research Questions 4.  Is there a difference in distress levels for PGAD women 
with partners compared to PGAD women without partners? 
H04: Level of distress will not be different for PGAD women without partners 
than for PGAD women with partners. 
H14: Level of distress will be different for PGAD women without partners than 
for PGAD women with partners. 
 I conducted a one-way ANOVA analysis to examine differences in sexual distress 
scores by relationship status. Fifty-one participants were again analyzed, with 38 women 
completing the BSSS scale (those who indicated they had partners and completed the 
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Berlin Social Support – Actually Received Support scale).  The independent variable 
(partnered) included two levels: women with partners and women without partners. The 
dependent variable was the FSDS-R score (sexual distress). The results indicated no 
statistically significant difference in FSDS-R scores between women with partners (n = 
38) and women without partners (n = 13), F(1,49) = .23, p = .630.  Mean FDSD-R scores 





Partner status M SD SE CI 
Partnered 23.54 13.72 4.06 [16.24,30.61] 
Not partnered 25.82 14.93 2.38 [21.22,31.02] 
 
Further Analyses 
Because several participants reported SSRI or other anti-depressant use, I used a 
Mann-Whitney U test (Table 11) on current, past and both current and past anti-
depressant use with sexual distress measured by the FSDS-R as the dependent variable.  
This test determined that there is no difference in women who are currently using one or 
more of these medications when compared to women who used these medications in the 
past, or when compared to women who are both currently using these medications and 



















Use of medication 
Current/Noncurrent 270.50 441.50 270.50 50.683 -.523 
.601 
Past/Non-past 193.00 1013.00 193.00 43.621          -.619 .536 
Both 326.00 579.00  326.00 52.527  .133 .894 
 
Comments from Open-Ended Questions 
 This is not an exhaustive review of the qualitative data, but selected as illustrative 
of the aforementioned points. 
First Open-Ended Question  
The first open-ended question sought to determine if participants felt there was a 
relationship between the onset of their PGAD and any specific trigger: “If participant 
answered “yes” to association of PGAD with a specific event, please specify event.”  Of 
the 51 respondents, 31 provided comments indicating potential triggers, the majority of 
which pertained to medication use or withdrawal.  One respondent indicated that 
“stopping SSRI trials (Prozac, Effexor, and Brintellix)” may have triggered the onset of 
her PGAD.  Another respondent indicated a trigger of “switching my "cocktail" of 
antidepressants around”.  A third respondent indicated “I'm not sure if it was stopping the 
Prozac or a fall but they happened at the same time”; while a fourth similarly indicated 
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“the abrupt discontinuation of SSRI”.  Other responses included “birth control pills. Also 
Pn nerve injury from Zumba” and “pregnancy” as possible triggers. 
Second open-ended question  
The second open-ended question sought information on how the respondent’s life 
was affected by PGAD:  “Please describe what ways, if any, PGAD has affected your 
life.” 
Of the 51 respondents, all of them supplied comments to this question.  One 
respondent describes how she “had to quit my career job early. I became dependent on 
pain meds. I can't make solid appointments. I feel like an invalid much of the time. 
PGAD intrudes at the worst times.”  Another respondent mentions how “over the years it 
has debilitated me. Cost me to lose my marriage. Has caused me to be unable to work. 
Depressed me.”  Another respondent has “dealt with suicidal thoughts, anxiety that lasts 
for days, and I have become very anti-social. PGAD dictates what I can and cannot do 
because my life is scheduled around my times of masturbation, which is every 7 to 10 
days. I have depression and suicidal ideation because of PGAD.”  Another respondent 
discusses how “pgad has destroyed my life.  I am unable to leave my house.  Unable to 
sit, unable to wear anything but very loose clothes, and am thoroughly miserable.  I miss 
intimacy.” Similary, another respondent indicates “It has ruined my life...causes me 




Third open-ended question  
The third open-ended question sought to hone in on which aspect of PGAD was 
having the most impact on the quality of life of the respondent:  “What aspects of PGAD, 
if any, do you feel have most impacted your quality of life?”  This is important to 
consider for therapeutic intervention of symptom management and increasing quality of 
life for these patients. 
Of the 51 respondents, all of them provided comments to this question.  One 
respondent wrote that “constantly being aroused never knowing if I can go outside or not. 
Mentally making me feel like I'm a freak. Cost me my family” impacted her quality of 
life.  Another respondent indicated “the pain, the embarrassment involved in seeking 
help, and the almost-impossibility of discussing it with anyone, even close friends. it's a 
very lonely condition.”  Another telling comment from one of the respondents was “I had 
to quit work which had affected our income.  We had to move our house we owned to a 
senior mobile home park.  I didn't try to get Disability until just recently and then they 
told me it was too late because I was already getting my Social Security.  Sometimes I 
just don't feel like I want to be with people because I feel too uncomfortable and I used to 
be such a people person!   The biggest thing I think that bothers me is that my brain is so 
off! It's just too difficult to concentrate! I miss so much or I forget and I'm sure this 
ongoing arousal has a lot to do with it!”  Another comment made was “I feel like I am 
useless and do not understand why I didn't just die in the OR” and similarly “Isolate 
myself at times don't want to go on.” 
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Finally, one of the longest comments by a respondent indicated “PGAD has 
altered my entire life. I have not been able to have a healthy sex life with my husband of 
21 years, I am limited as to being the kind of mother I'd like to be for my son, for 
example, I'd love to go see movies with him, spend more time with him, even at home, 
because I want to be supportive and involved in his life, but since his birth, my PGAD 
has limited our relationship, because it turns my mind inward, and I retreat to my own, 
quiet space where nothing will disturb my fragile state of mind. Before PGAD I was out 
going, able to socialize, spend time with family, focus on other people and travel. All of 
this has been taken away by PGAD. Now that other health issues are arising, such as I 
found out yesterday that I have osteoarthritis, I honestly fear the future. My father killed 
himself in 2007 in my front yard due to chronic pain, and I fear every day that that is how 
my life will end, and I fear the pain I know it will inflict upon my family.” 
Summary 
 In chapter 4, I provided an outline of the results of the four research 
questions under study, as well as several frequencies and descriptive analyses.   Analysis 
of the survey data indicated anxiety was not the strongest predictor of sexual distress in 
women with PGAD.  Utilizing the FSDS-R (Female Sexual Distress Scale – Revised) as 
a measure of sexual distress, I concluded the strongest predictor of the three predictors 
under study using the DASS-21 (Depression Anxiety and Stress Scale – 21 items) turned 
out to be depression.  .   Neither erotophobia/erotophilia nor the nature of partner support 
moderated the effect of depression on sexual distress measured by the FSDS-R.  There 
was also no significant difference between the group of participants with partners and the 
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group of participants without partners.   Samples were provided of comments received for 
the three open-ended questions asked in the survey.  
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of the study was to examine predictors (anxiety, depression, stress) 
and moderators (erotophobia/erotophilia and partner support) of sexual distress in women 
with PGAD.  I measured these variables using the DASS-21, the FSDS-R, the SOS, and 
the BSSS. 
In the study, I examined (a) whether or not anxiety would be the strongest 
predictor, (b) whether or not erotophobia-erotophilia moderated the relationship between 
the strongest predictor and the level of sexual distress, (c) whether or not the nature of 
perceived partner support moderated the relationship between the strongest predictor and 
the level of sexual distress measured by the FSDS-R, and (d) whether or not there is a 
difference in sexual distress levels for PGAD women with partners compared to PGAD 
women without partners.  In this chapter, I provide a detailed discussion and 
interpretation of the results presented in Chapter 4.  Limitations of the study, 
recommendations for future studies, and implications for social changed will also be 
provided. 
The Significant Predictors 
Correlations 
I found statistically significant correlations among depression, anxiety, and stress. 
Also, age was significantly correlated with depression and stress.  Interestingly, 
differences in mean scores on each of the DASS-21 subscales (anxiety, depression, 
stress) as well as the FSDS-R were quite noticeable when comparing scores with 
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employment status, with those being non-employed having the highest mean scores.  
Still, cause and effect conclusions cannot be drawn given that the study was a cross-
sectional single-point in time, and not longitudinal in nature.  It can be hypothesized, 
however, that the distress experienced from PGAD symptomatology make it difficult for 
women with PGAD to hold a job.  The comments provided to the open-ended questions 
further strengthen this hypothesis.   
While there was no evidence to suggest any one of the underlying conditions 
presented in the survey (Tarlov cysts, restless leg syndrome, overactive bladder, pudendal 
neuropathy, and sexually transmitted infections) was significantly correlated with sexual 
distress, many of the participants are facing multiple medical diagnoses from the 
aforementioned which did correlate with sexual distress.  Interestingly, multiple medical 
diagnoses were not correlated to depression, possibly due to the large antidepressant 
usage reported by participants.  Number of pregnancies was also significantly correlated 
with sexual distress.  It could be hypothesized that this correlation was due in part to 
respondents seeking relief of symptoms and ultimately becoming pregnant.  It could also 
be hypothesized that the number of pregnancies contributed to the onset of the symptoms 
of PGAD indirectly due to subsequent pregnancy-related etiologies such as pelvic floor 
concerns, bladder concerns, or nerve related issues.  Bilgic and Kizilkaya Beji (2014) 
discussed the potential role risk factors such as pregnancy and pelvic floor muscle 
atrophy on sexual dysfunction and quality of life for women with lower urinary tract 
symptoms.  Both number of medical diagnoses and number of pregnancies should be 
examined in more depth in future  research to explore cause and effect. 
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No correlations were found between sexuality, religion, spirituality, number of 
births, erotophobia-erotophilia, or partner support with sexual distress.  It is possible that 
correlations were lacking with respect to sexuality and erotophobia/erotophilia due to 
lack of diversity in the responses to these questions.  The majority of respondents were 
heterosexual or predominantly heterosexual, and levels of erotophobia were low.  Most of 
the respondents had average scores on the erotophobia/erotophilia scale, falling 
somewhere in-between, or in the neutral range. Similarly, a wide range of diversity did 
not present itself in the area of religion. While more diversity was present in the area of 
spirituality, it could simply be that sexual distress resulting from symptoms of PGAD 
does not discriminate based on spirituality, religion, or sexuality.  Further discussion on 
erotophobia-erotophilia and partner support appear later in the chapter.   
Duration of PGAD was also not correlated to sexual distress nor to age, 
depression, anxiety, or stress; however, age was significantly correlated to depression and 
stress.  Theoretically, it could be that sexual distress does not change over the duration of 
this particular disorder considering the nature PGAD symptomatology.  It could also be 
theorized that, given the cross-sectional nature of the study, it could simply be a matter of 
the current level of sexual distress at the time of the survey by those who were willing to 
participate.  Longitudinal studies may show changes in distress levels over the course of 
time, such as that in Cooley, Short, and Moriarty’s (2003) study of distress in patients 
with lung cancer.  
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Depression Versus Anxiety and Stress as Predictors 
  Given findings from prior studies suggesting the possibility that symptoms are 
due to high sensitivity towards one’s self and one’s surroundings (Leiblum & Chivers, 
2007; Leiblum, Seehuus, Goldmeier, & Brown, 2007), I hypothesized that anxiety would 
be the most significant predictor of the three psychological factors under study.  I further 
based this hypothesis on the model proposed by Leiblum and Chivers (2007) whereby it 
was suggested that women’s appraisal, response and potential hypersensitivity to 
detection  and awareness of genital sensations may cause them to experience anxiety, 
triggering the sympathetic nervous system to arouse and enhance their not only their 
perception and awareness of the genital sensations but also their attentiveness to such 
sensations.  Interestingly, although anxiety had a statistically significant correlation to 
sexual distress, when competing with depression as a predictor, it did not add to the 
prediction, nor did stress.  Instead, depression severity surfaced as the best statistically 
significant predictor of the three psychological factors under study.  Although several 
prior studies have noted high rates of depression in PGAD participants as assessed by 
self-report (Pink, Rancourt & Gordon , 2014; Leiblum et al., 2005), only one prior study 
has assessed depression, anxiety, or stress with the use of a validated measure like the 
DASS. Validated measures provide more thorough constructs of the factors being 
measured.  Garvey et al. (2009) noted the use of the Hospital Anxiety and Depression 
Scale in a study assessing spontaneous genital arousal and PGAD of clients of a walk-in 
sexual health clinic in London; however only one participant in their study of 96 
participants indicated having all five criteria of PGAD.   
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Theories Behind the Results 
 There are several relevant theories that bear on my interpretation of the results; 
however, this exercise is made extremely challenging due to the overlap between the 
certain aspects of the underlying constructs of depression, anxiety, and stress.    
To begin with, although depression is prevalent in anxious individuals and vice 
versa (Tiller, 2013), the construct of depression is clearly distinct from the construct of 
anxiety.  Early research by Lazarus (1991) showed that anxiety is constructed as a 
response to perceived threat, whereas depression is a response to perceived loss (i.e. loss 
of self-worth, interest, person(s), job, tangible assets).    
Anxiety has historically been understood within two divergent constructs: (a) as 
an acute emotion (state anxiety), or (b) as a personality construct (trait anxiety).  State 
anxiety is generally defined as an unpleasant emotional arousal in the face of a threat or 
danger stimulus, with a cognitive appraisal of a threat as a prerequisite for the experience 
of this emotion (Lazarus, 1991).  Conversely, trait anxiety is thought to reflect the 
existence of stable individual tendency to respond with state anxiety in the anticipation of 
threatening situations. 
Further complicating the picture, at the level of both state and trait anxiety, is a 
delineation that has been proposed between worry and emotionality (Spielberger, 1980), 
with worry referring to the cognitive component of the anxiety experience, and 
emotionality referring to the perceived arousal component of the anxiety experience. 
Although these two components are usually present at the same time to some degree, they 
are only poorly- to moderately-related to each other.  Importantly, worry is negatively 
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correlated with perceived self-efficacy (Schwarzer, 1996).  Thus, people who do not feel 
able to cope with challenging situations may experience self-doubts and worry, thus 
becoming more anxious.   
Last, a stress response may include an anxiety component, but not always.   As 
researchers such as Endler (1997) and Keane, Taylor, and Penk (1997) noted, stress may 
implicitly be thought of in the following means: (a) as a stimulus or stressor; (b) as a 
response to such a stressor which would be deemed as symptoms experienced; (c) or as a 
situational encounter experienced by an individual.  
Understanding the Current Findings 
First, depression surfacing as the strongest predictor over anxiety and stress is 
interesting.  Depression may be present as a response to loss, and it is easy to understand 
how these women who have experienced loss of normalcy could develop such symptoms, 
and that these would indeed predict distress.  Prior PGAD research does point to 
depression as a prominent psychological factor in PGAD cases.  For example, Eibye and 
Morch Jensen (2014) discussed the case of a patient hospitalized in a psychiatric unit and 
diagnosed with agitated depression upon the onset of PGAD.  Notably, the onset of 
PGAD occurred after the cessation of paroxetine, an antidepressant she had been taking 
for a history of anxiety and depression. Leiblum et al. (2007) noted early on in their 
PGAD research studies that depression was more likely to be present in women that met 
all criteria for PGAD than in women who did not (55% compared to 38%), and that they 
were also more likely to be anxious.  In some cases depression may occur before the 
onset of PGAD and in other cases after the onset of PGAD.  Yet, in other cases the 
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temporal relationships remains unclear. Undoubtedly, it is still valid to hypothesize that 
the loss of normalcy experienced by women contributes to the development or worsening 
of depressive symptoms and sexual distress. 
Depression has also been highly associated with chronic pain disorders (Knaster, 
Estlander, Karlsson, Kaprio & Kalso, 2016).  Extensive volumes of literature can be 
found examining the comorbidity of chronic pain and depression (Outcalt et al., 2015).  
Pink et al. (2014) noted that over half of the 15 participants in their PGAD study 
indicated pain as a symptom of their PGAD.   Given the consideration that PGAD is not a 
disorder of sexual dysfunction, it could be suggested that PGAD potentially be 
categorized as a pain disorder; perhaps a subcategory of pelvic pain. 
Turning to anxiety, it is reasonable to consider that both state and trait anxiety 
may be present in women with PGAD; however, to properly test this hypothesis would 
require a more precise assessment of anxiety using a measure such as the State-Trait 
Anxiety Inventory [STAI] (Spielberger, 1983).  This is a self-report inventory consisting 
of 20 items assessing state anxiety and another 20 items assessing trait anxiety.   
If state anxiety is considered as a specific response to an event or stimulus 
considered as threatening, then it is easy to see how cognitive recognition of unwanted 
intrusive genital sensations would cause women who experience PGAD symptoms to 
experience state anxiety.  It is possible that coping mechanisms are a factor; although this 
was not examined in this study so can only be theorized as an explanation for why 
anxiety, while being present, is not a predictor of sexual distress in this study, and instead 
may be a contributor, along with stress, to depressive symptoms that appear to be 
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prevalent in the majority of the study participants both prior to the onset of and after 
initiation of PGAD symptoms.  This, however, does not explain the women who 
indicated they have had PGAD since early childhood or prior to any experience of 
depression or the intake of antidepressant medication.  In these women, it may be that 
trait anxiety is present.  It is plausible that some women with trait anxiety, when 
experiencing unintended or unwanted genital stimulation, process it against a propensity 
for anticipation of such a stimulus.  Thus the possibility exist that state anxiety, trait 
anxiety, or both may be present in women experiencing PGAD. It is difficult to compare 
anxiety in this study to prior PGAD studies since only one used a validated anxiety 
instrument and only one patient in that study presented with PGAD. Further studies are 
needed that examine anxiety in more depth in women with PGAD; that delve into the 
intricacies of the physiological and psychological effects of anxiety and how or if these 
effects may or may not be contributing to PGAD.  Gathering historical information on 
respondents’ anxiety along with current information and measuring anxiety levels over 
time during the course of their PGAD can add to the significant gap in the current 
literature.  
Turning to stress, it can be considered as one of the following:  (a) as a stimulus 
or stressor; (b) as a response to such a stressor which would be deemed as symptoms 
experienced; (c) or as a situational encounter experienced by an individual.   Against this 
background, one can understand women with PGAD experiencing significant stress 
contributing to anxiety following PGAD symptoms as a critical event or as a part of the 
response pattern in anticipation of same, yet not predicting sexual distress per se. 
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  Last, another explanation for anxiety or stress not being significant predictors of 
sexual distress could be individualized allostatic responses.  Allostasis is defined as “the 
process of achieving and maintaining stability in the internal environment” (Kendall-
Tackett, 2010, p. 184).  Research suggests that gender-specific coping mechanisms play a 
role in perceived stress, allostatic load (stressors impeding allostasis), and responses.  
This contributes to stress-induced neurobehavioral disorders such as anxiety and 
depression.  With that said, it can be hypothesized that stress, while not being a 
statistically significant predictor of sexual distress, can indirectly contribute to such 
distress by directly contributing to depression, a significant predictor among PGAD 
sufferers in this sample under study.  
 Another factor to consider, as mentioned previously, is the instrument I used in 
this study, which may not have been extensive enough to capture significant anxiety and 
stress levels considering each psychological factor consisted of only 7 questions each.  
Since this is the first PGAD study to use a validated measure of anxiety, depression and 
stress, aside from the one study previously discussed that used the Hospital Anxiety and 
Depression Scale whereby only one patient presented with PGAD, it is difficult to 
determine the strength of the instrument used. Further research should seek to use both 
this instrument again as well as more extensive measurements of psychological factors. 
Signals in the Medical Backgrounds and Comments 
The results are less puzzling upon consideration of two further items: the 
correlation of multiple medical diagnoses to FSDS-R distress levels faced by many of the 
participants, and the examination of the comments provided by the participants in the two 
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open-ended questions assessing the impact of PGAD on their lives.  It could be 
hypothesized that the combination of multiple medical diagnoses could be a sign of an 
overall syndrome that has been manifesting itself through multiple outlets.  This would 
need considerable resources to expand the research in future studies such as physical 
examinations, laboratory tests, etc.  It could also be hypothesized that the combination of 
multiple medical diagnoses with PGAD could potentially contribute to one’s depression, 
even though the correlation in this dissertation did not exist.  The lack of correlation in 
this study could be due to the high rate of anti-depressant use by participants.  Also, I did 
not study coping mechanisms for psychological factors (depression, anxiety, and stress) 
in this dissertation.   
In a study of 7,620 Australian participants from primary care facilities, Gunn and 
associates (2012) noted that rates of depression increased as comorbidity of chronic 
illnesses increased.  This begs the question as to whether other underlying medical 
diagnoses could be an etiological factor among PGAD patients that have yet to be 
presented in current literature, such as autoimmune disorders or other chronic illnesses.  
The comments provided by the participants in the open-ended questions of the 
survey offer many evocative reflections and considerations as to possible explanations of 
why depression was found to be the most significant predictor.  For example, the 
comments included remarks regarding: low quality of life; life is ruined; depression; quit 
working; crippling; worthless; ruined sex life; miserable; want to die; withdrawn; 
distress, distracting; difficult to concentrate; hopelessness.  Many of the respondents 
could no longer hold jobs or could only work part-time.  Similar quality of life concerns 
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can be found among other chronic illnesses such as fibromyalgia.   Bernard, Prince and 
Edsall (2000) noted comparable conclusions with respect to quality of life in 
fibromyalgia patients, including poor mental health, reduced functionality in career 
management and negative impact on personal relationships.  Whether these items 
contributed to anxiety, stress and depression levels or vice versa are difficult to assess in 
a cross-sectional study.  Longitudinal studies would provide better opportunities for 
evaluation of which may occur first.  
Possible Connection to SSRIs/SNRIs 
Comment after comment suggests the poor quality of life for women with PGAD.  
Many have been on antidepressants either in the past or are currently using these 
medications.  In fact, antidepressant use, including SSRIs/SNRIs, was quite high in this 
study.  Over three-quarters of the participants have used one or more of these medications 
in the past, while nearly 50% are using them currently.  Medications reportedly used 
include:  citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, 
duloxetine, venlafaxine, milnacipran, bupropion, mirtazapine, nefazodone, trazodone, 
vilazodone, and vortioxetine. 
While cause and effect cannot be assessed here regarding the relationship between 
depression and PGAD, it is of note that 16 of the 51 participants reported the onset of 
their PGAD in close temporal proximity to either starting, changing, or withdrawing from 
antidepressant therapy, which suggests that depressive symptomatology preceded the 
PGAD and not the reverse.  This is not to suggest that depression causes PGAD; but 
rather to consider the large number of respondents who indicated SSRI use and/or 
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withdrawal prior to onset of PGAD symptoms.  It is reasonable to suggest further 
research into the effects of SSRI use and withdrawal and why these drugs could 
potentially cause symptoms such as those related to PGAD.  Also, while there is face 
validity to the hypothesis that PGAD could also cause depressive symptoms, this is 
clearly a line of enquiry worth further exploration.   Future studies should examine the 
onset of depression compared to the onset of PGAD; the start of use and withdrawal of 
SSRIs compared to the onset of PGAD; and depression levels over time in women with 
PGAD. 
Since so many respondents reported PGAD symptoms in close proximity to SSRI 
use, it is important to examine the effects of an SSRI on the human brain.  Increases of 
serotonin (5-HT) levels act on several areas of the body such as the brain, the spinal cord 
and the GI tract.  Only 1-2% of serotonin resides in the brain (Lichtblau, 2011).   There 
are several 5-HT receptors – seven classes and fourteen known receptors (Nestler, 
Hyman, & Malenka, 2009).  Different 5-HT receptors act on different areas. Of these 5-
HT receptors, 5-HT1A and 5-HT2A receptors are found to be the key intermediaries of 
serotonergic stimulation of the hypothalamic-pituitary-adrenal axis of the brain (Hanley 
& Van de Kar, 2003).  The hypothalamus, located in the diencephalon portion of the 
brain, is considered to be the area of the brain responsible for satiety. An action on the 5-
HT2A receptor can have an effect on spinal reflexes related to orgasm and ejaculation, 
which can ultimately contribute to sexual dysfunction (Lichtblau, 2011).  Neuroscientist 
Jim Pfaus has conducted extensive research on pathways of sexual desire.  He thoroughly 
examined the relationship between excitation, inhibition, neurochemical and 
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neuroanatomical systems and how neurotransmitters such as serotonin play a role in these 
and satiety.    Pfaus (2009) noted that serotonin neurons arising from the midbrain propel 
axonal projections to several sites throughout the brain, including the hypothalamus, as 
well as to the spinal cord and lower lumbar-sacral regions controlling genital reflexes.  It 
is reasonable then, considering the work of Pfaus and the findings of the current study to 
hypothesize that sudden stoppage of a serotonin reuptake inhibitor, causing a sudden drop 
in 5-HT, may be causing a “short-circuit” of the neurons of the hypothalamus, brainstem 
and spinal reflexes associated with sexual arousal and orgasm, reducing the ability to 
recognize satiety of sexual response and arousal thereby allowing arousal to reach 
extreme heights.  Hence, the high rate of respondents indicating that PGAD began upon 
sudden withdrawal of SSRIs.  
A new study by King, Goldstein and Pfaus (2016) found that treatment given for 
sleep (zolpidem, also known as Ambien) in a PGAD patient subsequently provided 
significant, though temporary, relief of PGAD symptoms.  Zolpidem is a fast-acting 
sedative-hypnotic, indirect GABA A receptor agonist with a short half-life of 2-3 hours 
that initiates a GABA release while inhibiting dopamine release, thereby releasing 
serotonin.  This study further supports the aforementioned hypothesis that serotonin may 
be playing a significant role in the brain circuitry of patients with PGAD. 
With depression appearing to be so prevalent among PGAD sufferers, it is 
important for the healthcare community to consider treatment options that not only target 
PGAD physical symptoms, but also the psychological symptoms that coincide.  Given the 
history of many of these patients with pharmacological therapies, antidepressants may not 
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be the best or only treatment solution for targeting depression in these patients.  
Clinicians may want to also consider treatment plans that include such strategies as 
cognitive behavioral therapy or other forms of non-pharmacological treatments. 
The FSDS-R  
In hindsight, a significant oversight in the early work of Lieblum and others was 
the failure to delve into the experience of distress in a systematic, in-depth manner.  In 
her seminal papers first characterizing the disorder, the presence of distress using the 
criteria of “the persistent feelings of genital arousal feel intrusive and unwanted” was 
apparently captured using a single item rating distress on a scale of 1-10, whereby 1-3 
was low, 4-7 was moderate and 8-10 was high.  A valid measure of sexually-related 
distress was never utilized.  Despite this, in 2007  the disorder was re-conceptualized 
from persistent sexual arousal syndrome to a non-sexual disorder by Leiblum et al. 
(2007), leading to a change in nomenclature from sexual to genital arousal disorder as the 
arousal was noted as genital in nature but not triggered by sexual stimuli or thoughts. Of 
note, the nomenclature change was not based on evidence that sexuality was not affected 
or distressing but rather on the basis of the observation that the symptoms of arousal were 
present in the absence of sexual stimuli.   Prior studies, however, did not use a valid 
measure of distress such as the FSDS-R to measure sexual distress in this population.  
Although PGAD may not necessarily be a disorder of sexual arousal, the severity of 
sexual distress that it can cause in women with PGAD may be overlooked by clinicians 
as a result of the de-emphasis on sexual arousal. 
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 My study extends the information previously available and provides new 
evidence for further hypothesis generation by being the first to use the FSDS-R in a study 
of PGAD.  A score of greater than 11on the FSDS-R is considered the cutoff point for 
sexual distress discriminative of sexual dysfunction (DeRogatis et. al, 2008).  The high 
levels of sexually-related distress as assessed by the FSDS-R (mean 25.24) in my study 
demonstrates that women experience significant sexual distress, even if the origin of that 
distress is not based on sexual arousal in response to sexual cues / desire per se.   When 
compared to FSDS-R mean scores  from  studies of other categories of FSD, it is notable 
that the mean score from my study is as high or higher than found in the majority of 
studies where the instrument has been used.  For example, use of the FSDS-R in samples 
of women with hypoactive sexual desire disorder (HSDD) in a study by DeRogatis et al. 
(2011), reported mean FSDS-R scores were 24.73; while in a pilot study by Runels, 
Melnick, Debourbon and Roy (2014) for the treatment of women with painful intercourse 
and/or anorgasmia, the mean FSDS-R score prior to any treatment was 17.27.  Thus, the 
distress expressed by participants with PGAD in my study can be understood in to be in 
the more severe range of sexually-related distress.  It is possible that this severity reflects 
selection bias in that selection of women who have sought treatment and/or who have 
enough distress to join a support group may not reflect the severity in the overall 
population of women with PGAD.  Nevertheless, in the absence of other studies using 
valid measures of sexually-related distress, it is important to assume that such distress 
levels are likely.  This consideration of severity is also warranted considering the FSDS-
R was not created specifically for or validated in PGAD patients, and the high scores on 
99 
 
non-arousal related items suggest the possibility that the sexual distress that affects the 
lives of these women is far greater than simply the effect on genital arousal.   
My findings also suggest the possibility that re-conceptualizing PGAD for the last 
decade in a manner that deemphasizes the sexual impact of the disorder may have been 
premature and indeed, may have contributed to increasing the challenges women with the 
condition may experience in obtaining appropriate care.  As an example, while no one 
would consider spinal cord transection a sexual disorder, it is nevertheless well 
recognized that people with such a lesion may experience profound sexual dysfunction 
and indeed, care of spinal cord-injured patients is now considered incomplete without 
attention to the sexuality of the subject.  By illustrating the profound levels of sexual 
distress women with PGAD experience, my findings highlight the importance of 
providing holistic care for the sexual concerns these women experience, beyond focusing 
on the genital symptoms alone. 
Also important, as evidenced by the sample of comments displayed in chapter 4 
that participants provided on the three open-ended questions, the development of a 
PGAD-specific distress scale would be a valuable contribution to the study of PGAD.  
Comments provided revealed a significant negative impact on quality of life for women 
with PGAD beyond the sexual distress noted, ranging from inability to focus in all 
aspects of life and a profound effect on their ability to work, to the extreme extent of 
suicidal ideation; though it should be noted that poor quality of life could be influenced 
by other factors not necessarily related to PGAD.  For the average person, it would be 
similar to an itch that does not get relieved by scratching just once, such as in the case of 
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poison ivy; or similar to having a continuous eye twitch that won’t subside.  It is 
uncomfortable; not necessarily painful, but rather a constant feeling of discomfort which 
can be quite severe in some cases.  The comments provided by the participants reveal a 
multitude of reasons for the distress experienced.   
Comments provided by participants insinuate that loss of control over one’s life is 
a large contributor to distress.  As Wallston, Strudler Wallston, Smith, and Dobbins 
(1987) explain, loss of perceived control over internal states and behavior can have a 
significant impact on health and health outcomes.  By utilizing qualitative methodologies, 
measures could be generated that cover aspects regarding perceived control as well as 
other potential contributors to distress in people with PGAD and could include such 
questions as : on a scale of x to y, how much control do you feel you have over your life; 
are you distressed by feelings of physical pain and if so how distressed; are you 
distressed by inability to focus and if so how distressed; are you distressed by the thought 
of making plans and if so how distressed; are you distressed about holding a job and if so 
how distressed; are you distressed about embarrassment and if so how distressed; are you 
distressed about talking to your partner about your symptoms and if so how distressed.  
This could potentially yield better discrimination from distressed versus non-distressed or 
non-PGAD samples.   The development of such a PGAD-specific scale would advance 
research of PGAD given the current state of knowledge and our need to deepen our 





Another interesting and important finding in my study was the lack of moderation 
by erotophobia-erotophilia; nor was erotophobia-erotophilia correlated to or a significant 
predictor of sexual distress.  In a recent study, Carvalho et al. (2015) noted sexual 
conservatism as a significant predictor of distress during intercourse for their sample of 
women with PGAD.  These researchers, however, used the Sexual Dysfunctional Beliefs 
Questionnaire as opposed to the SOS, which could account for the difference in outcome.  
For the SOS, a mean score of 61 suggests that the respondents are in the neutral range of 
erotophobia-erotophilia.  As noted in chapter 2, prior research found erotophobia to be 
present in several studies of sexual dysfunction (Furnham & Hirandani, 2009; Fisher, 
Byrne, & White, 1983; Byrne & Kelley, 1986; Hall, Hogue, & Guo, 2014; Macapagal & 
Janssen, 2011; Wiegel, Scepkowski, & Barlow, 2007).  Sexual guilt, shame and fear of 
stigma were noted as relevant factors in many of these earlier studies (Cherner & 
Reissing, 2013).  Such was the case in a few of the comments provided by the 
participants of the present study (i.e. “it has made me feel wrong and dirty.  It has made 
me question who I was, who I am and what caused it.”); however, the prevalence of these 
comments is low.  Again, given the lack of erotophobia present in the study sample and 
the high incidence of erotophobia being empirically present in sexual dysfunction 
research, the case could be made that PGAD is not a disorder of sexually oriented 
dysfunction at all as previously noted.  However, given the scores of the FSDS-R 
provided in this study, it is also quite clear that while PGAD may not be grounded under 
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the realm of sexual dysfunction, it does appear to cause significant sexual distress 
coupled by a significant impact on quality of life.  This is similar to other illnesses, such 
as cancer, that while not stemming from sexual dysfunction can cause significant impact 
on sexuality, sexual distress and quality of life.  This leads to the idea that PGAD, while 
being associated with genital arousal, should be given consideration as a disorder that 
does not stem from a sexually-based etiology or negative affective responses to sexual 
stimuli as measure by the SOS, but rather some other biological pathological trigger that 
is intensified by and/or provokes psychological comorbidities such as depression and 
anxiety. Some clinicians are approaching PGAD from a non-sexual perspective.  Dr. 
Robert Echenberg of the Echenberg Institute for Pelvic and Sexual Pain who suggests 
PGAD is a pain disorder as opposed to a disorder of sexual dysfunction 
(http://www.instituteforwomeninpain.com/dr.-echenberg-answers-questions-on-pgad, 
2016).   
The findings of my study suggest that while these particular respondents are 
suffering from PGAD, the average respondent is not erotophobic as evidenced by the 
scores of the SOS.  This makes sense if PGAD is examined from the viewpoint of being a 
disorder without roots in sexual dysfunction, considering that erotophobia tends to be 
more prevalent in disorders of sexual dysfunction (Furnham & Hirandani, 2009; Fisher, 
Byrne, & White, 1983; Byrne & Kelley, 1986; Hall, Hogue, & Guo, 2014; Macapagal & 
Janssen, 2011; Wiegel, Scepkowski, & Barlow, 2007).  This may also factor in to why 
anxiety failed to be a significant predictor of sexual distress in this study of women with 
PGAD.   Studies suggest that negative emotions such as anxiety are related to factors 
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such as sex-guilt and shame, significant characteristics found in erotophobia (Furnham & 
Hiranandani, 2009).  It can also be proposed that the finding may be a product of the 
small convenience sample used for the present study.  Future studies should strive to 
capture larger samples. 
Partner Support 
Finally, the findings on partner support, while not found to be a moderating 
variable to sexual distress measured by the FSDS-R, nor statistically different sexual 
distress levels among the group with partners and the group without partners, are not 
inconsistent with literature describing a variety of individualized characteristics and 
perceptions on the part of the recipient of partner support.  For example, while not all 
women in the study had partners (70.5% with, 29.5% without), it is feasible to theorize 
that those who did may behold a variety of avoidance-type traits, including some with 
high attachment avoidance and some with low attachment avoidance (Girme, Overall, 
Simpson & Fletcher, 2015; Dewitte, 2012).  As discussed in chapter 2, high attachment 
avoidance traits are conducive to higher erotophobia levels (Peloquin, Bigras, Brassard & 
Godbout, 2014).  In my study, erotophobia levels were low to average.  This would be 
conducive to my findings of no statistically significant moderation of partner support, 
particularly if the study participant sample has a low level of high attachment avoidance 
traits.  Unfortunately, conclusions cannot be drawn regarding avoidance traits in this 
study.   
It is quite possible that some participants of this study view particular features of 
partner support as adequate while others may view the same support as inadequate 
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(Brock & Lawrence, 2014).  Unless these factors are examined through additional 
validated questionnaires and potentially involve surveying the partners as well, it is likely 
that fluctuations in research findings will continue to occur.  Carvalho et al. (2015), while 
using the Dyadic Adjustment Scale Seven-Item Version as opposed to the Berlin Social 
Support – Actually Received Support scale, had similar findings of no statistically 
moderating significance of marital/relationship adjustment to severity of PGAD distress; 
they did find marital/relationship adjustment to be a significant predictor of PGAD 
distress when used as an independent variable as opposed to a moderator.  While my 
study did not find partner support to be correlated to or a significant predictor of PGAD, 
it could again be theorized that individual personalities and perceptions of adequate 
partner support contribute to this finding.   
For those without partners, it is possible that other means of support are available 
to this group such as family, friends, or the online support group.  This group may use the 
healthcare setting as their means of support.  Further inquiry into support systems would 
need to be conducted in future studies for those without partners.  
Future studies observing partner support should consider adding in questionnaires 
that examine high versus low attachment traits as well as overprovision versus 
underprovision of support.   Such measures will allow researchers to determine if the 
results of a scale such as the BSSS are in conjunction with the type of traits prevalent in 
the respondents of their studies.    They should also consider including partners’ 
responses in future study.  This could lead to valuable insight as to how PGAD affects 
relationships and family quality of life. 
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Quality of Life 
Of importance to note is that while partner support did not moderate FSDS-R 
measured sexual distress in my study, other social factors that were not measured by 
scales do potentially contribute to the distress of several respondents.  As the comments 
noted in chapter 4 reveal, PGAD sufferers are putting their lives on hold, quitting jobs, 
withdrawing from friends, family and life in general, avoiding situations where they need 
to leave their homes for long periods of time, and becoming isolated due to their 
symptoms.  Some have remarked about embarrassment and shame.  Some have suicidal 
ideation.  Some have seen several clinicians with little relief, and some fear the clinicians 
are not hearing them or taking them seriously.  This is not an exhaustive review of the 
qualitative data, but selected as illustrative of the aforementioned points. 
Interestingly, when comparisons were made between the SDSM group and the 
online support group, depression scores were higher in the SDSM group.  While several 
hypotheses can be made regarding these results (i.e. - this could suggest that the women 
from the SDSM group sought out treatment because they were more depressed than those 
in the online support group, or that the support received from other members of the online 
support group experiencing similar symptoms can provide a significant psychological 
benefit to PGAD sufferers) no generalizations regarding this finding can be substantiated 
until further research is conducted on quality of life concerns.  Encouragement for PGAD 





PGAD is a debilitating disorder; its sufferers endure a variety of physically, 
psychologically and socially distressing symptoms.  Quality of life can potentially be 
severely impacted by this relatively unknown, seemingly rare disorder.  The etiology of 
PGAD remains a mystery.  Earlier studies of PGAD posited a variety of theoretical 
etiologies including biological, neurological, psychological, pharmacological and 
vascular.  Anxiety, depression and stress have been targeted as potential triggers or 
exacerbating influencers of PGAD (Leiblum & Chivers, 2007; Leiblum, Seehuus, 
Golmeier, & Brown, 2007; Leiblum et al., 2005).  Others studies have noted underlying 
factors such as conservative sexual beliefs to have a significant correlation with PGAD 
(Carvalho, Verissimo, & Nobre, 2015).  Literature on PGAD remains deficient.   A 
handful of case reports have been presented as well as some studies with relatively small 
sample sizes.  PGAD literature is lacking in all areas, including longitudinal studies and 
larger studies to further elucidate the many etiologies proposed. 
My study has supplied evidence that PGAD is a paradoxical disorder in that while 
not triggered by sexual stimuli nor associated with negative affective responses to sexual 
stimuli as determined by the SOS scores, it is manifested in disordered genital response 
and is nevertheless experienced as profoundly distressing to the sexuality of women 
experiencing the condition.  Clinicians need to be aware of the high levels of sexual 
distress and encourage open discussions with patients to better assist with the 
development of treatment plans. 
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The finding that depression is a serious concomitant disorder in women with 
PGAD, whether the women are partnered or not, warrants continued assessment and 
close monitoring by clinicians caring for this population.  Suicidal ideation is a recurring 
theme among this group and several suicides attributed to PGAD have occurred within 
the online support group (but not within the study sample) during August of 2016.  The 
findings are indicative of the importance of utilizing the biopsychosocial framework 
model in the PGAD patient population given we still have no clear understanding of 
etiology or natural disease.  Biological, psychological and social aspects should all be 
taken into consideration when forming treatment plans for these patients.  Not only 
should healthcare clinicians seek to reduce or eliminate the physical symptoms 
(biological) of this disorder, but the psychological and social symptoms should be 
addressed as well.  Quality of life scales should be a consideration when designing future 
studies of PGAD.  These women, both partnered and un-partnered,  are not only suffering 
from the biological symptoms PGAD, they are also suffering from psychological 
symptoms such as depression and social symptoms such as the inability to live a quality 
life (i.e. – no longer work, no longer make plans, no longer interact with friends and 
family).  For those without partners, support groups can assist in providing psychological 
benefit by serving as an outlet for PGAD patients to share their stories, compare 
symptomatology, and reap the benefits from shared experience and understanding.   
Limitations of the Study 
Limitations of the study include the small sample size and correlational design 
methodology which limits interpretability of the relationships found.  Power calculations 
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indicated a sample of 64 would have been appropriate.  After eliminating those 
participants that did not qualify from the original sample of 73 respondents, I was left 
with a smaller than desired sample of only 51 participants.  As a result of the smaller 
sample size, the study may have been underpowered, perhaps contributing to the 
statistical significance of the results throughout the study.  Secondly, participants were 
recruited from an online support group venue in addition to a clinician’s database.  
Several participants indicated they did not have an official diagnosis of PGAD and were 
self-reporting their disorder, which can contribute to bias being present in the study.  
Finally, a third limitation was the use of the FSDS-R, a validated scale examining female 
sexual distress as determination of distress in women with PGAD.  This was due to the 
lack of a scale focusing on PGAD specific distress.  No generalizations can be made from 
this study regarding cause and effect. 
Recommendations 
Recommendations from my study include performing larger, multinational studies 
in the future in order to generate data on the impact of culture on the disorder and to 
begin to better understand the epidemiology and natural history of the condition and 
provide more generalization to the population.  Other recommendations include further 
studies of SSRI/antidepressant use in PGAD sufferers given the number of respondents 
who reported their use and the onset of PGAD upon cessation of use.  It may be possible 
to query large pharma company datasets of SSRI adverse events to ascertain this 
phenomenon.  Future studies should also consider the use of a valid suicidal ideation 
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scale as well as utilizing psychological therapies for PGAD sufferers in hopes of reducing 
depression and suicide rates in conjunction with providing coping strategies.   
Given that the majority of the variance in sexual distress in the sample cannot be 
accounted for, future work should strive to better understand the nature of the distress 
these women experience beyond the realm of sexual distress.  I also suggest using more 
extensive psychological measurements for anxiety, depression and stress in future 
studies, including measurements examining perceived control.  Considering the multiple 
medical diagnoses reported by participants, future studies may want to consider other 
underlying medical conditions that may be found to be common among PGAD patients 
such as autoimmune disorders for example.  
Implications for Social Change 
 Implications for social change are significant.  Women with PGAD have a high 
rate of depression.  Spotting this depression early on while working through other PGAD 
treatment strategies can encourage early treatment and control of depression, and 
subsequently lower suicide rates from this terrible disorder.  The comments collected in 
my study from the participants are indicative of a group of women who are pleading for 
help from our healthcare system.  They want to be heard.  They want answers.  They 
want to be taken seriously. They want their suffering to end.  They want their lives back.  
For this to occur, more PGAD research needs to be done.   Healthcare clinicians need to 
be educated on this disorder and they need to take their patients complaints and cries for 
help seriously.  This study needs to be presented to clinicians around the globe who can 
work to help treat the depressive symptoms of PGAD while searching for other 
110 
 
underlying pathology.  Publications from my study can form a positive contribution to the 
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 Appendix A: Scales and Questionnaires 
DEMOGRAPHICS 
1. Did you receive this survey invitation from?  
(Select only one.) 
  1 – an email from San Diego Sexual Medicine 
  2 – FacebookTM support group 
 
2. What is your age?  
 
_______ (Enter age) 
 
3. What country do you reside in?  
 
____________________ (Enter country) 
 
4. What is your race?  
(Select only one.) 
  1- Caucasian 
  2 - African American/Black 
  3 - Asian 
  4 - Native American/Alaska Native 
      5 - Native Hawaiin/Other Pacific Islander 
      6 - Latino/a 
      7 - Multiracial (please specify) ____________________ 
  8 - Other (please specify) ________________________ 
 
5. What is the highest level of education you have completed?  
(Select only one.) 
  1 - High School Diploma  
  2 - Associates degree 
  3 - Bachelor’s degree 
  4 - Master's degree 
  5 – Doctorate degree 
  6 – Other (please specify) __________ 
 
6. How would you describe your current Religious affiliation? 
(Select only one.) 
  1 - Christian 
  2 - Jewish 
  3 - Muslim 
  4 - Buddhist 
  5 - Hindu 
  6 - Sikh 
  7 - Atheist / Agnostic 
133 
 
  8 - No religious affiliation 
  9 - Other (please specify) _______ 
 
7. To what extent, if at all, do you consider yourself religious (an organized systems of 
worship that gives a framework to the relationship we have with the universe and with a 
higher power)?  
(Select only one.) 
  1 – Not at all Religious 
  2 – Slightly Religious 
  3 – Somewhat Religious 
  4 – Quite Religious 
  5 – Extremely Religious 
 
8. To what extent, if at all, do you consider yourself spiritual (a sense of connection to the 
universe and to a higher power)?  
(Select only one.) 
  1 – Not at all Spiritual 
  2 – Slightly Spiritual 
  3 – Somewhat Spiritual 
  4 – Quite Spiritual 
  5 – Extremely Spiritual 
 
9. What is your employment status?  
  1 - Full time employed 
  2 - Part time employed 
  3 - Student 
  4 - Retired 
  5 - Non employed (i.e. – choose to stay home, in-between jobs, on 
disability) 
 
10. What is your household income?  
(Select only one.) 
  1 - < $25,000 per year 
  2 - $25,001 - $50,000 per year 
  3 - $50,001 - $75,000 per year 
  4 - $75,001 - $100,000 per year 
  5 - > $100,000 per year 
11. What is your relationship status?  
(Select only one.) 
  1 - Single 
  2 - Married 
  3 - Separated 
  4 - Divorced 
  5 – In a relationship, live with partner 
  6 – In a relationship, but not living with partner 
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12. Over our lifetime, sexuality is experienced as both psychological (thoughts, fantasy) 
and behavioral (activities we engage in) expression.  We often fantasize about activity 
that we never wish to, nor will actually engage in.  Rate yourself, in terms of your own 
fantasies over the course of your life, on the following scale:  
(Select only one.) 
  1 - Exclusively heterosexual (opposite sex), with no homosexual (same 
sex) 
  2 - Predominantly heterosexual, with only rare / incidental homosexual 
  3 - Predominantly heterosexual, but more than incidental homosexual 
  4 - Equally heterosexual and homosexual 
  5 - Predominantly homosexual, but more than incidental homosexual 
  6 - Predominantly homosexual, with only rare / incidental homosexual 
  7 - Exclusively homosexual, with no heterosexual 
 
13. Rate yourself, in terms of your own behavior with partners over the course of your 
life, on the following scale:  
(Select only one.) 
  1 - Exclusively heterosexual (opposite sex), with no homosexual (same 
sex) 
  2 - Predominantly heterosexual, with only rare / incidental homosexual 
  3 - Predominantly heterosexual, but more than incidental homosexual 
  4 - Equally heterosexual and homosexual 
  5 - Predominantly homosexual, but more than incidental homosexual 
  6 - Predominantly homosexual, with only rare / incidental homosexual 




 GYNECOLOGICAL AND MEDICAL HISTORY 
 
1. Please clarify which of the following symptoms you have experienced within the past 
six months: 
(Select all that apply.) 
  1 – Persistent feelings of arousal extending over days or weeks or 
months 
  2 – The arousal is not relieved by or only temporarily relieved by 
orgasm(s) 
  3 – The arousal is not associated with sexual thoughts or desire 
  4 – The arousal may be triggered by nonsexual stimuli or no apparent 
stimuli 
  5 – The arousal is bothersome and causes distress 
 
2. How long have you experienced symptoms of PGAD? 
______Number of months 
______Number of years  
 
3. During the past six months, how distressed have you been regarding your PGAD 
symptoms?  
(Select only one.) 
  0 – Not at all distressed 
  1 – Slightly distressed 
  2 – Somewhat distressed 
  3 – Quite distressed 
  4 – Extremely distressed 
 
4. During the past six months, how embarrassed have you been regarding your PGAD 
symptoms?  
(Select only one.) 
  0 – Not at all embarrassed 
  1 – Slightly embarrassed 
  2 – Somewhat embarrassed 
  3 – Quite embarrassed 
  4 – Extremely embarrassed 
 
5. Have you visited a health care provider regarding your PGAD symptoms?  
(Select only one.) 
  1 - Yes 
  2 - No 
 
6. How many separate health care providers have you seen regarding your PGAD 
symptoms? 
(Select only one.) 
  0 - I have not seen a health care provider for my PGAD symptoms 
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  1  
  2 
  3  
  4 or more 
 
7. Have you received a diagnosis of PGAD from a health care provider 
(Select only one.) 
  1 - Yes 
  2 - No 
 
 
8. Have you been satisfied with the support you have received from health care providers 
regarding your PGAD symptoms? 
(Select only one.) 
  1 – Not at all satisfied 
  2 – Slightly satisfied 
  3 – Somewhat satisfied 
  4 – Quite satisfied 
  5 – Extremely satisfied 
  6 – Other, please explain 
_______________________________________ 
 
9. Are you currently?  
(Select only one.) 
  1 - Pre-menopausal 
  2 - Peri-menopausal 
  3 - Post-menopausal 
  4 - Unknown 
10. How many times have you been pregnant?  
(Select only one.) 
  0 
  1 
  2 
  3 
    4 or more 
11. To how many children have you given birth?  
(Select only one.) 
  0 
  1 
  2 
  3 
  4 or more 
 
12. Did you have vaginal births or cesarean sections?  
  1 - Vaginal 
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  2 - Cesarean 
  3 - Both 
  4 - Neither – currently pregnant with first child 
  5 – Not Applicable - no children or have adopted/surrogate/partners 
children 
 
13. Have you ever been diagnosed with Overactive Bladder?  
  1 - Yes 
  2 – No 
 
14. Have you ever been diagnosed with Restless Leg Syndrome?  
  1 - Yes 
  2 – No 
 
15. Have you ever been diagnosed with Tarlov Cyst(s)?  
  1 - Yes 
  2 – No 
16. Have you ever been diagnosed with Pelvic Congestion Syndrome?  
  1 - Yes 
  2 – No 
17. Have you ever been diagnosed with Pudendal Neuropathy?  
  1 - Yes 
  2 - No 
18. Have you ever been diagnosed with a Sexually Transmitted Infection?  
  1 - Yes 
  2 – No 
The following questions are regarding prescription medications. 
19. Are you currently or have you taken in the past any of the following SSRI’s (selective 
serotonin reuptake inhibitor)/SNRI’s (selective norepinephrine reuptake inhibitor)?  
(Select all that apply)            
            
                      
           
  NAME    CURRENTLY                IN THE PAST            
  1  citalopram (Celexa)               
  2  escitalopram (Lexapro)                  
  3  fluoxetine (Prozac)                 
  4  fluvoxamine (Luvox)                  
  5  paroxetine (Paxil)                        
  6  sertraline (Zoloft)                 
  7  desvenlafaxine (Pristiq)                 
  8  duloxetine (Cymbalta)                 
  9  venlafaxine (Effexor)                  
10  milnacipran (Savella)                  
11  levomilnacipran (Fetzima)                 
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20. Are you currently or have you taken in the past any of the following other 
Antidepressants? 
(Select all that apply) 
            
                  
            
                 
  NAME    CURRENTLY                IN THE PAST             
1  bupropion (Wellbutrin)                
2  mirtazapine (Remeron)               
3  nefazodone (Serzone)                
4  trazodone (Desyrel, Oleptro)               
5  vilazodone (Vilbryd)                
6  vortioxetine (Brintellix)                
  
21. Do you associate the onset of your PGAD symptoms with any specific event (for 
example, stopping a medication)? 
 
  1 - Yes 
  2 – No 














 Below is a list of feelings and problems that women sometimes 
have concerning their sexuality.  Please read each item carefully, and 
circle the number that best describes HOW OFTEN THAT PROBLEM HAS 
BOTHERED YOU OR CAUSED YOU DISTRESS DURING THE PAST 7 
DAYS INCLUDING TODAY.  Check only one number for each item, 
and take care not to skip any items.   
 
Example: How often did you feel: Personal responsibility for your 
sexual problems. 
 
NEVER RARELY OCCASIONALLY FREQUENTLY ALWAYS 
   0             1                      2                          3                      4     
  
 
 HOW OFTEN DID YOU FEEL: 
 
 1. Distressed about your sex life    0   1   2   3   4 
 2. Unhappy about your sexual relationship  0   1   2   3   4 
 3. Guilty about sexual difficulties    0   1   2   3   4 
 4. Frustrated by your sexual problems   0   1   2   3   4 
 5. Stressed about sex     0   1   2   3   4 
 6. Inferior because of sexual problems   0   1   2   3   4 
 7. Worried about sex     0   1   2   3   4 
 8. Sexually inadequate     0   1   2   3   4 
 9. Regrets about your sexuality    0   1   2   3   4 
10. Embarrassed about sexual problems  0   1   2   3   4  
11. Dissatisfied with your sex life    0   1   2   3   4 
12. Angry about your sex life    0   1   2   3   4 
13. Bothered by low sexual desire    0   1   2   3   4 
 





Actually Received Support, Recipient 
Think about your current romantic partner. How did this person react to you during this 










1. The person showed me that he/she 
loves and accepts me. 
1 2 3 4 
2. This person comforted me when I was 
feeling bad. 
1 2 3 4 
3. This person left me alone. 1 2 3 4 
4. This person did not show much 
empathy for my situation. 
1 2 3 4 
5. This person criticized me. 1 2 3 4 
6. This person made me feel valued and 
important. 
1 2 3 4 
7. This person expressed concern about 
my condition. 
1 2 3 4 
8. This person assured me that I can rely 
completely on him/her. 
1 2 3 4 
9. This person encouraged me not to 
give up. 
1 2 3 4 
10. This person was there when I needed 
him/her. 
1 2 3 4 
11. This person took care of many things 
for me. 
1 2 3 4 
12. This person took care of things I 
could not manage on my own. 
1 2 3 4 
13. This person helped me find something 
positive in my situation. 
1 2 3 4 
14. This person suggested activities that 
might distract me. 
1 2 3 4 
 
                                                Satifaction with Support Received  
In general, I am very satifisfied with the way 
this person behaved. 




Please read each statement and circle a number 0, 1, 2, or 3 which indicates how much 
the statement applied to you over the past week. There are no right or wrong answers.  
Do not spend too much time on any statement. 
 
The rating scale is as follows: 
0 – Did not apply to me at all – NEVER 
1 – Applied to me to some degree, or some of the time – SOMETIMES 
2 – Applied to me to a considerable degree, or a good part of the time – OFTEN 
3 – Applied to me very much, or most of the time – ALMOST ALWAYS 
 
 NEVER SOMETIMES OFTEN ALMOST 
ALWAYS 
1. I found it hard to wind down 0 1 2 3 
2. I was aware of dryness of my mouth 0 1 2 3 
3. I couldn’t seem to experience any 
positive feeling at all 
0 1 2 3 
4. I experienced breathing difficulty (eg, 
excessively rapid breathing, 
breathlessness in the absence of 
physical exertion) 
0 1 2 3 
5. I found it difficult to work up the 
initiative to do things 
0 1 2 3 
6. I tended to over-react to situations 0 1 2 3 
7. I experienced trembling (eg, in the 
hands) 
0 1 2 3 
8. I felt that I was using a lot of nervious 
energy 
0 1 2 3 
9. I was worried about situations in 
which I might panic and make a fool 
of myself 
0 1 2 3 
10. I felt that I had nothing to look 
forward to 
0 1 2 3 
11. I found myself getting agitated 0 1 2 3 
12. I found it difficult to relax 0 1 2 3 
13. I felt down-hearted and blue 0 1 2 3 
14. I was intolerant of anything that kept 0 1 2 3 
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me from getting on with what I was 
doing 
15. I felt I was close to panic 0 1 2 3 
16. I was unable to become enthusiastic 
about anything 
0 1 2 3 
17. I felt I wasn’t worth much as a person 0 1 2 3 
18. I felt that I was rather touchy 0 1 2 3 
19. I was aware of the action of my heart 
in the absence of physcial exertion 
(eg, sense of heart rate increase, heart 
missing a beat) 
0 1 2 3 
20. I felt scared without any good reason 0 1 2 3 




Sexual Opinion Survey 
Please respond to each item as honestly as you can.  There are no right or wrong answers and your 
responses will be completely anonymous. 
 
1.  I think it would be very entertaining to look at hard-core erotica. 
 
 1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
2.  Erotica is obviously filthy and people should not try to describe it as anything 
else. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
3.  Swimming in the nude with a member of the opposite sex (with a member of my 
sexual interest) would be an exciting experience.  
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
4.  Masturbation can be an exciting experience. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
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 7 = strongly disagree 
 
5.  If I found out that a close friend of mine was homosexual, it would annoy me.  
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
6.  If people thought I was interested in oral sex, I would be embarrassed. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
7.  Engaging in group sex is an entertaining idea. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
8.  I personally find that thinking about engaging in sexual intercourse is arousing. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 








9.  Seeing an erotic movie would be sexually arousing to me. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
10. Thoughts that I might have homosexual tendencies would not worry me at all.  
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
11. The idea of my being physically attracted to members of the same sex is not 
depressing.  
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
12. Almost all erotic material is nauseating. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 








13. It would be emotionally upsetting to me to see someone exposing themselves 
publicly. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
14. Watching a stripper of the opposite sex would not be very exciting.  
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
15. I would not enjoy seeing an erotic movie. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
16. When I think about seeing pictures showing someone of the same sex as myself 
masturbating, it nauseates me.  
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 







17. The thought of engaging in unusual sex practices is highly arousing. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
18. Manipulating my genitals would probably be an arousing experience. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
19. I do not enjoy daydreaming about sexual matters. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 
 7 = strongly disagree 
 
20. I am curious about explicit erotica. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 










21. The thought of having long-term sexual relations with more than one sex partner 
is not disgusting to me. 
 
1 = strongly agree 
 2 = agree 
 3 = somewhat agree 
 4 = neutral 
 5 = somewhat disagree 
 6 = disagree 





1. Please describe what ways, if any, PGAD has affected your life. 




Appendix B: Email Invitation to Participate 
 
As a client of San Diego Sexual Medicine and a woman over the age of 17 who 
has been suffering from Persistent Genital Arousal Disorder (PGAD) for at least six 
months and currently meet the below criteria, you are cordially invited to take part in a 
research study being conducted by Walden University student, Lisa Squibb as her 
doctoral dissertation examining PGAD.  PGAD Criteria include:   
  1 – Persistent feelings of arousal extending over days or weeks or 
months 
  2 – The arousal is not relieved by or only temporarily relieved by 
orgasm(s) 
  3 – The arousal is not associated with sexual thoughts or desire 
  4 – The arousal may be triggered by nonsexual stimuli or no apparent 
stimuli 
  5 – The arousal is bothersome and causes distress 
 
The purpose of this study is to better understand associations of the psychological 
and relationship contributors to PGAD distress in women.  Your participation will 
contribute greatly to PGAD research and help provide valuable knowledge to clinicians, 
researchers and people around the globe. If you are interested, please click the following 
link to begin.   
 
Link to survey/informed consent will be provided here. 
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Appendix C: Online Support Group Invitation to Participate 
 
Are you a woman over the age of 17 who has been suffering from Persistent 
Genital Arousal Disorder (PGAD) for at least six months?  If yes, and you also meet the 
following criteria, you are invited to take part in a research study examining PGAD.  
PGAD Criteria include:   
  1 – Persistent feelings of arousal extending over days or weeks or 
months 
  2 – The arousal is not relieved by or only temporarily relieved by 
orgasm(s) 
  3 – The arousal is not associated with sexual thoughts or desire 
  4 – The arousal may be triggered by nonsexual stimuli or no apparent 
stimuli 
  5 – The arousal is bothersome and causes distress 
 
The study is being conducted as a Ph.D. doctoral dissertation by Walden 
University student, Lisa Squibb. The purpose of this study is to better understand 
associations of psychological and relationship contributors to PGAD distress in women.  
Your participation will contribute greatly to PGAD research and help provide valuable 
knowledge to clinicians, researchers and people around the globe. If you are interested, 
please click the following link to begin.   




Appendix D: Seven-day Follow-up Email Invitation to Participate 
 
Thank you for your consideration in taking part in the doctoral dissertation 
research study examining PGAD by Walden University student, Lisa Squibb. If you have 
already completed the survey, your participation is much appreciated.  If you have not 
had the opportunity, but would still like to participate, this email serves as a reminder that 
the survey is still open and available for participation.   
  As a reminder, your participation will contribute greatly to PGAD research and 
help provide valuable knowledge to clinicians, researchers and people around the globe. 
If you are interested, please click the following link to begin.  The link is provided here 
again for your convenience. 
 




Appendix E: Fourteen-Day Follow-Up Email Invitation to Participate 
 
Thank you for your consideration in taking part in the doctoral dissertation 
research study examining PGAD by Walden University student, Lisa Squibb.  If you 
have already completed the survey, your participation is much appreciated.  If you have 
not had the opportunity, but would still like to participate, this email serves as a reminder 
that the survey is still open and available for participation.  The survey will close in two 
weeks.   
  As a reminder, your participation will contribute greatly to PGAD research and 
help provide valuable knowledge to clinicians, researchers and people around the globe. 
If you are interested, please click the following link to begin.  The link is provided here 
again for your convenience. 
 




Appendix F: Seven-Day Follow-Up Online Support Group Invitation to Participate 
 
Thank you for your consideration in taking part in the doctoral dissertation 
research study examining PGAD by Walden University student, Lisa Squibb.  If you 
have already completed the survey, your participation is much appreciated.  If you have 
not had the opportunity, but would still like to participate, this notice serves as a reminder 
that the survey is still open and available for participation.   
  As a reminder, your participation will contribute greatly to PGAD research and 
help provide valuable knowledge to clinicians, researchers and people around the globe. 
If you are interested, please click the following link to begin.  The link is provided here 
again for your convenience. 
 




Appendix G: Fourteen-Day Follow-Up Online Support Group Invitation to Participate 
 
Thank you for your consideration in taking part in the doctoral dissertation 
research study examining PGAD by Walden University student, Lisa Squibb.  If you 
have already completed the survey, your participation is much appreciated.  If you have 
not had the opportunity, but would still like to participate, this notice serves as a reminder 
that the survey is still open and available for participation.  The survey will close in two 
weeks. 
  As a reminder, your participation will contribute greatly to PGAD research and 
help provide valuable knowledge to clinicians, researchers and people around the globe. 
If you are interested, please click the following link to begin.  The link is provided here 
again for your convenience. 
 
Link to survey/informed consent will be provided here. 
 
 
